
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Epidemiological profile and renal outcomes in a 25-year Brazilian cohort of glomerular diseases - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5346A88AF441D30546A8001DC93FB8.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jbrasnefro">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Jornal Brasileiro de Nefrologia">
<meta name="citation_title" content="Epidemiological profile and renal outcomes in a 25-year Brazilian cohort of glomerular diseases">
<meta name="citation_author" content="Fernando Sales">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_author" content="Priscylla Vieira do Carmo">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_author" content="Rosália Maria Nunes Henriques Huaira">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_author" content="Nicolas William Gonçalves de Almeida">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_author" content="Mateus Henrique Toledo Lourenço">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_author" content="Natália Maria da Silva Fernandes">
<meta name="citation_author_institution" content="Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.">
<meta name="citation_publication_date" content="2025 Aug 15">
<meta name="citation_volume" content="47">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="e20240213">
<meta name="citation_doi" content="10.1590/2175-8239-JBN-2024-0213en">
<meta name="citation_pmid" content="40815784">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/pdf/2175-8239-jbn-47-4-e20240213.pdf">
<meta name="description" content="Glomerular diseases (GD) are an important cause of chronic kidney disease (CKD). This study aims to analyze the socio-demographic, clinical, and renal outcome profiles of patients with GD. A retrospective cohort study was conducted between 1998 and ...">
<meta name="og:title" content="Epidemiological profile and renal outcomes in a 25-year Brazilian cohort of glomerular diseases">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Glomerular diseases (GD) are an important cause of chronic kidney disease (CKD). This study aims to analyze the socio-demographic, clinical, and renal outcome profiles of patients with GD. A retrospective cohort study was conducted between 1998 and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12356627">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1590/2175-8239-JBN-2024-0213en"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/2175-8239-jbn-47-4-e20240213.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12356627%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12356627/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12356627/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jbrasnefro.gif" alt="Jornal Brasileiro de Nefrologia logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Jornal Brasileiro de Nefrologia" title="Link to Jornal Brasileiro de Nefrologia" shape="default" href="http://www.bjn.org.br/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Bras Nefrol</button></div>. 2025 Aug 15;47(4):e20240213. doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2024-0213en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2024-0213en</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Bras%20Nefrol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><div class="font-secondary font-xs">
<span>View full-text in </span><a href="#s1" class="text-primary">Portuguese</a>
</div>
<section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Epidemiological profile and renal outcomes in a 25-year Brazilian cohort of glomerular diseases</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sales%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Fernando Sales</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Fernando Sales</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Conceptualization, Data curation, Investigation, Methodology, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sales%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fernando Sales</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22do%20Carmo%20PV%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Priscylla Vieira do Carmo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Priscylla Vieira do Carmo</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22do%20Carmo%20PV%22%5BAuthor%5D" class="usa-link"><span class="name western">Priscylla Vieira do Carmo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huaira%20RMNH%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Rosália Maria Nunes Henriques Huaira</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Formal analysis, Visualization</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huaira%20RMNH%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Almeida%20NWG%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Nicolas William Gonçalves de Almeida</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nicolas William Gonçalves de Almeida</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Almeida%20NWG%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicolas William Gonçalves de Almeida</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louren%C3%A7o%20MHT%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mateus Henrique Toledo Lourenço</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mateus Henrique Toledo Lourenço</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louren%C3%A7o%20MHT%22%5BAuthor%5D" class="usa-link"><span class="name western">Mateus Henrique Toledo Lourenço</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20NMDS%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Natália Maria da Silva Fernandes</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Natália Maria da Silva Fernandes</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div>Conceptualization, Formal analysis, Methodology, Supervision, Validation, Visualization, Writing – review and editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20NMDS%22%5BAuthor%5D" class="usa-link"><span class="name western">Natália Maria da Silva Fernandes</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brazil.</div>
<div class="author-notes p">
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">
<strong>Correspondence to:</strong> Fernando Sales. Email: <span>fernansales@gmail.com</span>
</p>
</div>
<div class="fn" id="fn1"><p><strong>Conflict of Interest:</strong> The authors declare that there is no conflict of interest.</p></div>
<div class="fn" id="FN1">
<p><strong>Editorial Responsibility:</strong> Editor-in-chief: Miguel C. Riella <a href="https://orcid.org/0000-0003-4181-613X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">0000-0003-4181-613X</a>.</p>
<p>Associate Editor: Luis Martin <a href="https://orcid.org/0000-0003-1435-7994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">0000-0003-1435-7994</a>.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Fernando Sales</span></strong>: <span class="role">Conceptualization, Data curation, Investigation, Methodology, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Priscylla Vieira do Carmo</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></strong>: <span class="role">Formal analysis, Visualization</span>
</div>
<div>
<strong class="contrib"><span class="name western">Nicolas William Gonçalves de Almeida</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mateus Henrique Toledo Lourenço</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Natália Maria da Silva Fernandes</span></strong>: <span class="role">Conceptualization, Formal analysis, Methodology, Supervision, Validation, Visualization, Writing – review and editing</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 30; Accepted 2025 May 5; Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12356627  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40815784/" class="usa-link">40815784</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Introduction:</h3>
<p>Glomerular diseases (GD) are an important cause of chronic kidney disease (CKD). This study aims to analyze the socio-demographic, clinical, and renal outcome profiles of patients with GD.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>A retrospective cohort study was conducted between 1998 and 2023. Participants were patients aged ≥ 18 years, diagnosed with GD, and treated at a university hospital in Brazil. Socio-demographic, clinical, histopathological, and kidney variables were analyzed. A comparative analysis was performed among the most frequent histopathological diagnoses. Renal survival was the outcome variable.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>We evaluated 417 patients, of whom 57.3% were women and 69.8% were white. The mean age was 41.7 ± 14.4 years. Primary glomerular diseases (PGD) accounted for 51.1%, and 77.5% of patients underwent a kidney biopsy. The most frequent PGD was membranous nephropathy (26.3%), while among the secondary glomerular diseases (SGD), lupus nephritis (LN) was the most common (51.9%). Minimal change disease was associated with better renal survival, whereas membranoproliferative glomerulonephritis had the worst outcomes (p = 0.001). Regarding CKD progression, a higher initial estimated glomerular filtration rate (eGFR) was protective (HR = 0.956, 95%CI: 0.920–0.994; p = 0.023), while the presence of interstitial fibrosis/tubular atrophy (IFTA) (HR = 1.079, 95%CI: 1.020–1.142; p = 0.008) and a higher body mass index (BMI) (HR = 1.257, 95%CI: 1.016–1.556; p = 0.035) were associated with increased risk of CKD progression.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion:</h3>
<p>LN remained the most common SGD in our region, while focal segmental glomerulosclerosis was the third most common PGD. Risk factors for worse outcome included a higher BMI, lower eGFR, and higher IFTA.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Cohort Studies; Renal Insufficiency, Chronic; Epidemiology; Glomerulonephritis; Pathology</p></section></section><section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<p>Chronic kidney disease (CKD) is considered one of the major public health challenges worldwide and an independent risk factor for cardiovascular diseases (CVD)<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup>. The estimated global prevalence of CKD across all five stages is 13.4% (11.7–15.1%), affecting more than 800 million people<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B4" class="usa-link" aria-describedby="B4">4</a>
</sup>. In Brazil, the national prevalence of chronic dialysis patients increased from 665 per million people in 2019 to 758 in 2022<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>.</p>
<p>Glomerular diseases (GD) are the third leading cause of dialytic CKD in Brazil and several other countries, following systemic arterial hypertension (SAH) and diabetes mellitus (DM)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B6" class="usa-link" aria-describedby="B6">6</a>
</sup>. These conditions comprise a heterogeneous group of disorders associated with high morbidity and mortality and a significant socioeconomic impact, given their role as a leading cause of dialysis-dependent CKD in young adults<sup>
<a href="#B6" class="usa-link" aria-describedby="B6">6</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B9" class="usa-link" aria-describedby="B9">9</a>
</sup>.</p>
<p>A 2018 international multicenter study analyzed 42,603 native kidney biopsies from 29 nephrology centers worldwide. In Latin America, lupus nephritis (LN) (38.1%) and focal segmental glomerulosclerosis (FSGS) (15.8%) were the most prevalent diagnoses<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>.</p>
<p>In 2010, a national survey on GD in Brazil included 9,617 renal biopsies, reporting that most patients were white (72.0%), female (51.0%), and from the Southeast region (47.0%), with a mean age of 35.07 ± 18.22 years. The primary indication for biopsy was nephrotic syndrome (NS) (39.0%), while acute kidney injury (AKI) was present in 14.4% of cases<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>
</sup>. LN (45.5%) was the most common secondary glomerular disease (SGD), whereas FSGS (24.6%) was the most frequent primary glomerular disease (PGD)<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>
</sup>, with a similar finding described in several previous Brazilian regional studies<sup>
<a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>.</p>
<p>The University Hospital of the Federal University of Juiz de Fora (HU/UFJF) provides nephrology care to patients from several municipalities in the Zona da Mata Mineira region. The hospital’s glomerular disease outpatient clinic serves as a reference center for the entire region. A previous study published in 2008 examined the epidemiological profile of GDs in the Zona da Mata Mineira region, analyzing 126 native kidney biopsies from adult patients between 1996 and 2006. The most common clinical presentation was NS (55.2%), while the most frequent histopathological diagnoses were FSGS (40.8%) among PGDs and LN (80.7%) among SGDs<sup>
<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>.</p>
<p>The last evaluation of this population was conducted 19 years ago, revealing an epidemiological profile that appears to have changed. Thus, this study aimed to conduct a new analysis of GD patterns, identify predominant clinical and histopathological presentations, and assess factors associated with kidney disease progression and outcomes.</p></section><section id="sec6"><h2 class="pmc_sec_title">Methods</h2>
<p>A retrospective cohort study was conducted from January 1998 to January 2023. The sample consisted of adult patients seen at the GD outpatient clinic of the UFJF Nephrology Department.</p>
<p>The inclusion criteria were a confirmed diagnosis of GD (with or without kidney biopsy) and aged ≥18 years. The exclusion criteria were late-stage GD diagnosis (chronic glomerulonephritis), ongoing renal replacement therapy (RRT), or a previous history of kidney transplantation. Chronic glomerulonephritis was defined as severe loss of kidney function (eGFR &lt; 20–30 mL/min per 1.73 m<sup>2</sup>) associated with extensive and irreversible renal damage (primarily interstitial fibrosis and tubular atrophy and/or bilateral renal atrophy), in which no ongoing therapeutic approach could reasonably alter the natural course of kidney function decline<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>
</sup>.</p>
<p>Data were collected from patients’ medical records, with variables categorized based on admission, follow-up, and the end of follow-up. Sociodemographic, clinical, laboratory, renal outcome, and histopatholo­gical data were extracted.</p>
<p>The following variables were analyzed: admission variables (sociodemographic data, associated comorbidities, social and family history of nephropathy, initial nephrological presentation, and classification of GD as primary or secondary<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>); biopsy variables (age at biopsy, number of biopsies performed, diagnosis, and histopathological features).</p>
<p>SGD are defined as glomerular disorders with an identifiable underlying or systemic cause, such as infections, autoimmune, and rheumatic diseases (e.g., systemic lupus erythematosus and small vessel vasculitis), drug-induced glomerular injury (either direct or autoimmune-mediated), and cancers, including solid tumors and hematologic malignancies. In contrast, PGD are characterized by localized or intrinsic renal pathology<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>For FSGS, primary cases were defined as those presenting with full NS and no identifiable secondary cause. When available, electron microscopy confirmed these cases by demonstrating diffuse foot process effacement in podocytes. Secondary FSGS was characterized by the same histological pattern but was linked to underlying pathophysiological mechanisms, such as viral infections, drug exposure, glomerular hyperfiltration-induced injury, or adaptive processes. These cases typically lacked severe proteinuria and/or full NS, and electron microscopy, when available, did not reveal diffuse podocyte effacement<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>The outcome variables analyzed included initial and final eGFR, initial and final proteinuria, and clinical outcomes (active follow-up at the outpatient clinic, loss to follow-up, discharge to a CKD outpatient clinic, discharge from nephrology, initiation of RRT, and death).</p>
<p>Follow-up variables included follow-up duration, clinical data from initial and final consultations, body mass index (BMI), systolic (SBP) and diastolic blood pressure (DBP), and laboratory results at baseline and end of follow-up. Laboratory assessments included eGFR calculation using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula<sup>
<a href="#B20" class="usa-link" aria-describedby="B20">20</a>
</sup> and proteinuria quantification through 24-hour urine collection or the protein-to-creatinine ratio from an isolated sample.</p>
<p>For patients who did not undergo kidney biopsy, GD diagnosis was based on persistent compatible clinical and laboratory findings, including dysmorphic hematuria and/or proteinuria, and the absence of diabetes mellitus, nephrolithiasis, or urinary tract infection<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics and Research Committee of the University Hospital of UFJF (CAAE: 47019521.9.0000.5133).</p>
<section id="sec7"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Descriptive statistical analysis results were reported as means, standard deviations, medians, or frequencies, depending on the type of variable (numerical or categorical) and its distribution (assessed using the Kolmogorov-Smirnov test). Comparative ana­lyses were conducted between the most frequent histopathological diagnoses and cases without renal biopsy. Statistical tests included the chi-square test, Student’s t-test, ANOVA, or the Mann-Whitney test, depending on the variable’s characteristics. Paired t-tests were conducted to compare initial versus final eGFR, while non-parametric tests were used for initial versus final proteinuria in related samples. Renal survival analysis was performed using Kaplan-Meier survival curves, with comparisons assessed using the log-rank test. Cox regression analysis was performed to evaluate renal survival as the outcome variable, adjusting for confounding factors with biological and/or statistical plausibility. The temporal evolution of histopathological diagnoses was analyzed, with frequencies expressed as percentages over specific time intervals. All statistical tests were conducted with a 95% confidence interval (CI). Statistical analyses were performed using SPSS version 17.0 (Chicago, Illinois<sup>®</sup>).</p></section></section><section id="sec8"><h2 class="pmc_sec_title">Results</h2>
<section id="sec9"><h3 class="pmc_sec_title">Study Population</h3>
<p>A total of 472 patients from the Nephrology GD outpatient clinic at UFJF were selected (January 1998 to January 2023). Forty-one patients were excluded as they were under the age of 18 and 14 were excluded as kidney biopsies indicated non-GD or chronic glomerulonephritis, leading to a final sample of 417 patients (<a href="#F1" class="usa-link">Figure 1</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Study flowchart.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/2bf6b17c2304/2175-8239-jbn-47-4-e20240213-gf01.jpg" loading="lazy" height="469" width="800" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec10"><h3 class="pmc_sec_title">Population Characteristics</h3>
<p>Among the 417 patients, the mean age was 41.7 ± 14.4 years, with 57.3% were women and 69.8% reported being white. Most (66.7%) reported a family income of up to two minimum wages, 58.3% had an education level ranging from incomplete secondary education to higher education, and 72.1% were employed. A total of 323 patients (77.5%) underwent kidney biopsy, and 13% required a repeat biopsy for therapeutic or prognostic purposes.</p>
<p>The most frequent histopathological diagnoses were LN, followed by FSGS, IgA nephropathy (IgAN), and membranous nephropathy (MN) (<a href="#F2" class="usa-link">Figure 2</a>). PGDs accounted for 51.1% of cases, with primary MN being the most frequent subtype. Among SGDs, LN and secondary FSGS were the most common conditions (<a href="#F3" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Histopathological diagnosis of glomerular diseases.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/79b10df9dcec/2175-8239-jbn-47-4-e20240213-gf02.jpg" loading="lazy" height="466" width="760" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abbreviations – LN (Lupus Nephritis), IgAN (IgA Nephropathy), MN (Membranous Nephropathy), FSGS (Focal and Segmental Glomerulosclerosis), MCD (Minimal Change Disease), Normal biopsy in UAS (Normal kidney biopsy in urinary abnormalities syndrome), MPGN (Membranoproliferative Glomerulonephritis), AAV (ANCA-associated vasculitis), Other glomerular diseases (fibrillary glomerulonephritis; non-IgA mesangial glomeru­lonephritis; crescentic glomerulonephritis not classified in previous GDs; thrombotic microangiopathy), Infection-related GN (Infection-related Glomerulonephritis), Undefined diagnosis (Undefined histological diagnosis), MGRS (Monoclonal gammopathy of renal significance).</p></figcaption></figure><figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Histopathological diagnosis of primary and secondary glomerular diseases.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf03.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/38005fbc5dc1/2175-8239-jbn-47-4-e20240213-gf03.jpg" loading="lazy" height="315" width="760" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abbreviations – PGD (primary glomerular diseases), SGD (secondary glomerular diseases), LN (Lupus Nephritis), IgAN (IgA Nephropathy), MN (Membranous Nephropathy), FSGS (Focal and Segmental Glomerulosclerosis), MCD (Minimal Change Disease), Normal biopsy in UAS (Normal kidney biopsy in urinary abnormalities syndrome), MPGN (Membranoproliferative Glomerulonephritis), AAV (ANCA-associated vasculitis), Other (Other GD), p (primary), s (secondary).</p></figcaption></figure><p>The most common comorbidities were SAH, dyslipidemia, and psychiatric illnesses. Additionally, 29.7% of patients were current or former smokers, and 18.7% had CVD (<a href="#T1" class="usa-link">Table 1</a>). At baseline, 78.0% had a BMI ≥ 25 (<a href="#T1" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1. Total clinical data, by histological type of glomerular disease and in non-biopsied cases.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="top" rowspan="1" colspan="1">Total</th>
<th align="center" valign="top" rowspan="1" colspan="1">LN</th>
<th align="center" valign="top" rowspan="1" colspan="1">IgAN</th>
<th align="center" valign="top" rowspan="1" colspan="1">MN</th>
<th align="center" valign="top" rowspan="1" colspan="1">FSGS</th>
<th align="center" valign="top" rowspan="1" colspan="1">MCD</th>
<th align="center" valign="top" rowspan="1" colspan="1">AAV</th>
<th align="center" valign="top" rowspan="1" colspan="1">MPGN</th>
<th align="center" valign="top" rowspan="1" colspan="1">Other<sup>‡</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">Non-biopsied</th>
<th align="center" valign="top" rowspan="1" colspan="1">p</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age<a href="#T1FN2" class="usa-link"><sup>*</sup></a> (Years, Mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41.7 (14.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.8 (10.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37.5 (12.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.9 (14.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38.3 (13.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.7 (14.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52.3 (17.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.0 (14.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43.9 (14.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">White People (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">82.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">79.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.012</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Women (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">82.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hypertension (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">88.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">65.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diabetes (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">27.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.098</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Dyslipidemia (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">53.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">35.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.062</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cardiovascular diseases (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">32.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.021</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Current or former smoking (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">29.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">46.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">32.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">30</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">39.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Psychiatric disease (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">56.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Bone disease (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.320</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">SBP initial<a href="#T1FN2" class="usa-link"><sup>*</sup></a> (mmHg, Mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">135.3 (23.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">139.6 (26.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">137.3 (21.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">135.2 (27.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">139.1 (21.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">125.1 (12.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">123.1 (11.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">165.6 (28.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">134.4 (22.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">130.1 (20.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">DBP initial<a href="#T1FN2" class="usa-link"><sup>*</sup></a> (mmHg, Mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.1 (14.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87.7 (16.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87.4 (13.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83.8 (13.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87.9 (13.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.4 (10.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">77.8 (10.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.4 (14.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83.7 (13.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">82.3 (14.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">BMI initial<a href="#T1FN2" class="usa-link"><sup>*</sup></a> (% ≥25, kg/m<sup>2</sup>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">71.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">82.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">76.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">76.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.600</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Antiproteinuric (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">89.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">93.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">96.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">71.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">SGLT2i (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diuretics (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">73.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">77.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">46.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">84.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">93.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">52.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Statins (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">53.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">88.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">57.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">46.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Imunossupression (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">72.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">93.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Corticosteroids (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">55.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">93.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">IV Pulse therapy (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Nephrologic presentation (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Nephrotic syndrome</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">53.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">96.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.5</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Nephritic syndrome</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">6.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Nephritic-nephrotic syndrome</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Isolated hematuria</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.6</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Isolated subnephrotic proteinuria</td>
<td align="center" valign="top" rowspan="1" colspan="1">14.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">25.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.5</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hematuria with subnephrotic proteinuria</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">58.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Isolated nephrotic proteinuria</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">No data</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial AKI (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">70.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">RPGN (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial dialysis (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Family history present (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">35.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T1FN1"><p>Abbreviations – LN (Lupus Nephritis); IgAN (IgA Nephropathy); MN (Membranous Nephropathy); FSGS (Focal and Segmental Glomerulosclerosis; MCD (Minimal Change Disease); MPGN (Membranoproliferative Glomerulonephritis); AAV (ANCA-associated vasculitis); Other (Other glomerular disease: renal amyloidosis, monoclonal gammopathy of renal significance, glomerulonephritis associated with infection, normal biopsy with hematuria and/or subnephrotic proteinuria, fibrillary glomerulonephritis, non-IgA mesangial glomerulonephritis, crescentic glomerulonephritis not classified in previous glomerular diseases, thrombotic microangiopathy, no defined histological diagnosis); Non-biopsied (No kidney biopsy); SD (standard deviation); % (percentage); &lt; (minor); ≥ (greater than or equal to); Cardiovascular diseases (Heart failure, or Coronary artery disease, or Cerebrovascular disease, or Peripheral arterial disease, or Rheumatic heart disease, excluding systemic arterial hypertension); SBP (systolic blood pressure); DBP (diastolic blood pressure); BMI (body mass index); Antiproteinuric (Angiotensin-converting enzyme inhibitors, or angiotensin II receptor blockers, or aldosterone blockers, or sodium-glucose cotransporter 2 inhibitors); SGLT2i (sodium-glucose cotransporter 2 inhibitors); Diuretics (loop diuretic, or thiazide diuretic, or aldosterone blocker); IV Pulse therapy (Intravenous Pulse Therapy); AKI (acute kidney injury); RPGN (rapidly progressive glomerulonephritis);</p></div>
<div class="fn" id="T1FN2"><p>*(at the beginning of the follow-up).</p></div>
</div></section><p>Regarding medication use, 89.2% of patients were prescribed antiproteinuric drugs, 73.4% used diuretics, and 61.1% received immunosuppressive therapy, predominantly corticosteroids (59%). Pulse therapy with corticosteroids and/or cyclophosphamide was administered to 30.7% (<a href="#T1" class="usa-link">Table 1</a>).</p>
<p>The main nephrological clinical presentation was NS (33.8%), followed by hematuria with subnephrotic proteinuria (24.2%), and isolated subnephrotic proteinuria (14.9%). AKI was observed in 15.5% of patients, rapidly progressive glomerulonephritis (RPGN) in 8.7%, and 4.3% required dialysis (<a href="#T1" class="usa-link">Table 1</a>). Family history of nephropathy was reported in 23.3% (<a href="#T1" class="usa-link">Table 1</a>), with a higher prevalence among those with family members who required dialysis or kidney transplantation (37.4%).</p>
<p>Among patients who underwent kidney biopsy, 61.8% had interstitial fibrosis and tubular atrophy (IFTA), averaging 20.0% (±15.8%) of IFTA. Glomerular sclerosis was detected in 69.3%, vascular lesions in 44.4%, and crescents in 23.8% (predominantly cellular crescents, 40.5%) (<a href="#T2" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2. Histopathological, laboratory and clinical outcome data by histological type of glomerular disease and in non-biopsied cases.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="top" rowspan="1" colspan="1">Total</th>
<th align="center" valign="top" rowspan="1" colspan="1">LN</th>
<th align="center" valign="top" rowspan="1" colspan="1">IgAN</th>
<th align="center" valign="top" rowspan="1" colspan="1">MN</th>
<th align="center" valign="top" rowspan="1" colspan="1">FSGS</th>
<th align="center" valign="top" rowspan="1" colspan="1">MCD</th>
<th align="center" valign="top" rowspan="1" colspan="1">AAV</th>
<th align="center" valign="top" rowspan="1" colspan="1">MPGN</th>
<th align="center" valign="top" rowspan="1" colspan="1">Other<sup>‡</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">Non-biopsied</th>
<th align="center" valign="top" rowspan="1" colspan="1">p</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">eGFR (Mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial</td>
<td align="center" valign="top" rowspan="1" colspan="1">72.9 (33.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79.7 (35.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.0 (29.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78.1 (30.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67.8 (32.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91.8 (28.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.5 (39.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">42.6 (26.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65.3 (38.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">76.3 (29.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Final</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.5 (33.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">73.6 (34.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.3 (28.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60.0 (32.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.8 (28.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.4 (24.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.0 (32.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32.3 (15.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">51.7 (31.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70.8 (30.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">eGFR initial <em>vs</em>. final</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>p &lt; 0.001</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinuria (Mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.7 (4.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.9 (2.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.9 (3.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.9 (4.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.0 (4.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.6 (4.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1 (1.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3 (3.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.6 (2.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 (1.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Final</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 (2.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9 (1.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.1 (1.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.3 (2.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.2 (2.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7 (1.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 (1.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.2 (5.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.0 (1.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.9 (2.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinuria initial <em>vs</em>. final</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>p &lt; 0.001</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Number of biopsies (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">87.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">83.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">89.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">≥2</td>
<td align="center" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crescents (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">% of IFTA (mean, SD)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0 (15.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.0 (12.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0 (19.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0 (13.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20.0 (15.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.0 (5.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.0 (16.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.5 (12.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37.5 (18.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.25</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total or partial glomerular sclerosis (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">88.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">51.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">46.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">71.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Vascular injury (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">37.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">44.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.010</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Follow-up in months (median, IQR)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.0 <br>(12–99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52.0 <br>(19–66)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.0 <br>(13–124)</td>
<td align="center" valign="top" rowspan="1" colspan="1">68.0 <br>(24.3–134.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0 <br>(18.8–99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">77.5 <br>(24.8–124)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.0 <br>(4.5–57.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16.5 <br>(12.3–29.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.0 <br>(7.5–77.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40.0 <br>(10–80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.019</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Clinical outcome (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.002</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Active in outpatient clinic</td>
<td align="center" valign="top" rowspan="1" colspan="1">61.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">77.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">62.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">59.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">63.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">72.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">50.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">44.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">53.2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Loss to follow-up</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.4</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.9</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Transfer to conservative CKD outpatient clinic</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">15.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.6</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Dialysis</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.1</td>
<td align="center" valign="top" rowspan="1" colspan="1">30.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Death</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Discharge from Nephrology follow-up</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T2FN1"><p>Abbreviations – LN (Lupus Nephritis); IgAN (IgA Nephropathy); MN (Membranous Nephropathy); FSGS (Focal and Segmental Glomerulosclerosis; MCD (Minimal Change Disease); MPGN (Membranoproliferative Glomerulonephritis); AAV (ANCA-associated vasculitis); Other (Other glomerular disease: renal amyloidosis, monoclonal gammopathy of renal significance, glomerulonephritis associated with infection, normal biopsy with hematuria and/or subnephrotic proteinuria, fibrillary glomerulonephritis, non-IgA mesangial glomerulonephritis, crescentic glomerulonephritis not classified in previous glomerular diseases, thrombotic microangiopathy, no defined histological diagnosis); Non-biopsied (No kidney biopsy); eGFR (estimated glomerular filtration rate); SD(standard deviation); % (percentage); IQR (interquartile range); &lt; (minor); = (greater than or equal to); IFTA (interstitial fibrosis and tubular atrophy); CKD (chronic kidney disease).</p></div></div></section></section><section id="sec11"><h3 class="pmc_sec_title">Comparison of Histological Diagnoses and Non-Biopsied Cases</h3>
<p>Patients with LN had the lowest average age, while those with membranoproliferative glomerulone­phritis (MPGN) had the highest age. LN was more frequent in females, whereas ANCA-associated vasculitis (AAV) and MN predominated in males. All cases of AAV were observed in white patients (<a href="#T1" class="usa-link">Table 1</a>).</p>
<p>MPGN was associated with 100% prevalence of SAH, whereas minimal change disease (MCD) had the lowest (63.3%). Psychiatric disorders were more common in patients with MCD, and MPGN patients had the highest prevalence of smoking. CVDs were more frequent in MPGN and FSGS patients (<a href="#T1" class="usa-link">Table 1</a>). MPGN was associated with significantly higher initial SBP (p &lt; 0.001) and DBP (p = 0.004) (<a href="#T1" class="usa-link">Table 1</a>).</p>
<p>Medication usage varied across groups: antiproteinuric drugs were used by all MCD and FSGS patients and 71.3% of non-biopsied cases (p &lt; 0.001). Diuretics were most frequently prescribed for MPGN (100%), MCD (93.3%), MN (92%), and FSGS (84.6%) patients (p &lt; 0.001). Statins were most frequently prescribed in AAV (90.9%) and MN (88%) (p &lt; 0.001), while SGLT2 inhibitors were mostly commonly used in IgAN patients (31.4%) (p &lt; 0.001) (<a href="#T1" class="usa-link">Table 1</a>).</p>
<p>Immunosuppressive therapy was administered in all LN and AAV cases and was also prevalent in MCD (93.3%) and MN (72.9%) (p &lt; 0.001). NS predominated in MCD (96.7%), MN (92%), and FSGS (53.8%) patients. RPGN was most frequent in AAV (60.0%) and LN (20.3%), whereas no cases were observed in MCD or MN (p &lt; 0.001). AAV had the highest dialysis requirement (30.0%) (p &lt; 0.001) (<a href="#T1" class="usa-link">Table 1</a>).</p>
<p>Histopathological analysis revealed more crescents in AAV (100%) and LN (45.5%) (p &lt; 0.001), while IFTA was more common in MPGN (88.9%), IgAN (80%), and FSGS (79.1%) (p &lt; 0.001). Glomerular sclerosis (total or segmental, excluding FSGS) was prevalent in IgAN (88.1%) and AAV (85.7%) cases but less frequent in MCD cases (46.7%) (p &lt; 0.001) (<a href="#T2" class="usa-link">Table 2</a>).</p></section><section id="sec12"><h3 class="pmc_sec_title">Outcomes</h3>
<p>During follow-up, the mean eGFR declined from 72.9 ± 33.3 to 62.5 ± 33.0 (p &lt; 0.001), while proteinuria decreased from 3.7 ± 4.0 to 1.3 ± 2.1 (p &lt; 0.001) (<a href="#T2" class="usa-link">Table 2</a>). MCD showed the best renal survival, while MPGN had the poorest outcomes (<a href="#F4" class="usa-link">Figure 4</a>). Most patients (61.4%) remained in follow-up, with low rates of chronic RRT (4.6%) or mortality (1.2%) (<a href="#T2" class="usa-link">Table 2</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. Renal survival curve (Kaplan-Meier) in the comparison of the main diagnoses of glomerular diseases (log rank 0.001).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf04.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/b34c87bb40d1/2175-8239-jbn-47-4-e20240213-gf04.jpg" loading="lazy" height="479" width="760" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abbreviations – LN (Lupus Nephritis), IgAN (IgA Nephropathy), MN (Membranous Nephropathy), FSGS (Focal and Segmental Glomerulosclerosis), MCD (Minimal Change Disease), MPGN (Membranoproliferative Glomerulonephritis), AAV (ANCA-associated vasculitis), Others (Others GD: renal amyloidosis; monoclonal gammopathy of renal significance; glomerulonephritis associated with infection; normal biopsy with hematuria and/or subnephrotic proteinuria; fibrillary glomerulonephritis; non-IgA mesangial glomerulonephritis; crescentic glomerulonephritis not classified in previous GDs; thrombotic microangiopathy; no defined histological diagnosis), No kidney biopsy (No Biopsy).</p></figcaption></figure><p>Cox regression analysis identified protective factors to CKD progression, including higher baseline eGFR (HR = 0.956, 95%CI: 0.920–0.994; p = 0.023). Risk factors for CKD progression included the presence of IFTA (HR = 1.079, 95%CI: 1.020–1.142; p = 0.008) and higher BMI (HR = 1.257, 95%CI: 1.016–1.556; p = 0.035) (<a href="#T3" class="usa-link">Table 3</a>).</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3. Cox regression analysis.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead>
<tr><th align="center" colspan="4" valign="top" rowspan="1">Cox regression analysis: outcome renal survival adjusted for confounders</th></tr>
<tr style="border-top:solid black 0.1em;border-bottom:solid black 0.1em; border-color: #000000">
<th align="center" valign="top" rowspan="1" colspan="1"></th>
<th align="center" valign="top" rowspan="1" colspan="1">HR</th>
<th align="center" valign="top" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="top" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at diagnosis of GD</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.041</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.955–1.134</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.366</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sex feminine</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.163</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.022–1.211</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.076</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial eGFR</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.956</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.920–0.994</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.023</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial proteinuria</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.932</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.687–1.263</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.648</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">DM (diagnosis present)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.985</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.153–6.348</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.988</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Initial BMI</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.257</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.016–1.556</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.035</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">IFTA</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.079</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.020–1.142</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0.008</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">ACE inhibitors or angiotensin receptor blocker (use)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83.3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.420–16502.754</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.101</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression (use)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.626</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.080–4.881</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.655</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T3FN1"><p>Abbreviations – GD: glomerular disease; eGFR: estimated glomerular filtration rate; DM: diabetes mellitus; BMI: body mass index; IFTA: interstitial fibrosis and tubular atrophy; ACE: Angiotensin-converting enzyme inhibitor; IFTA: interstitial fibrosis and tubular atrophy; HR: Hazard ratio; CI: Confidence interval.</p></div></div></section><p>Over time, the prevalence of LN cases increased, while podocytopathies (MCD and FSGS) declined and IgAN remained stable (<a href="#F5" class="usa-link">Figure 5</a>).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5. Temporal evolution of the prevalence of the main histopathological diagnoses of glomerular diseases from January 1998 to January 2023.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf05.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/d2a5fdf71f55/2175-8239-jbn-47-4-e20240213-gf05.jpg" loading="lazy" height="527" width="760" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abbreviations – LN (Lupus Nephritis), IgAN (IgA Nephropathy), MN (Membranous Nephropathy), FSGS (Focal and Segmental Glomerulosclerosis), MCD (Minimal Change Disease), MPGN (Membranoproliferative Glomerulonephritis), AAV (ANCA-associated vasculitis).</p></figcaption></figure></section></section><section id="sec13"><h2 class="pmc_sec_title">Discussion</h2>
<p>Our study confirmed a shift in the epidemiological profile of GD in the region over the past 25 years. It provided new insights by incorporating renal outcome data alongside prevalence rates and histopathological diagnosis descriptions.</p>
<p>A multinational study examining GD frequency across Europe, North America, Latin America, and Asia reported a median age of 47.3 years (39.7–56.9), with 53% of patients being male and 57% identifying as white<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>. Latin American patients were younger and predominantly female, aligning with our findings. This demographic profile, characterized by a predominance of young female patients, is likely linked to the high prevalence of LN in Latin America and in Brazil, suggesting a possible genetic component<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>
</sup>.</p>
<p>Regarding this aspect, a significant proportion of patients (23.3%) reported a family history of nephropathy, reinforcing the genetic influence on GD<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>
</sup>. A genetic study of 163 patients with CKD of unknown etiology (2016–2020) identified a definitive genetic diagnosis in 31% of the 100 patients with GD<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. Exome sequencing of 111 cases of idiopathic NS revealed no pathogenic variants in the corticosteroid-sensitive group, whereas 30% of corticosteroid-resistant cases harbored pathogenic variants in genes associated with podocytopathies<sup>
<a href="#B24" class="usa-link" aria-describedby="B24">24</a>
</sup>.</p>
<p>This population exhibited a high cardiovascular risk, with significant comorbidities and clinical events, aligning with previous studies that highlight the connection between traditional cardiovascular risk factors and GD-specific factors, including their treatment<sup>
<a href="#B25" class="usa-link" aria-describedby="B25">25</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>. A cohort study of 1,912 patients with PGD (IgAN, FSGS, MCD, or MN) found that the cardiovascular event rate in this population was 2.5 times higher than in the general population, with FSGS patients exhibiting the highest risk<sup>
<a href="#B25" class="usa-link" aria-describedby="B25">25</a>
</sup>. A Danish population-based cohort of 1,644 systemic lupus erythematosus (SLE) patients identified a significantly higher risk of acute myocardial infarction (AMI) (eight-fold increase) and cardiovascular mortality (four-fold increase) in SLE patients with LN compared to those without LN<sup>
<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>.</p>
<p>Additionally, psychiatric disorders were more frequent in disease subgroups requiring higher corticosteroid use—the primary immunosuppressive therapy in our study—reinforcing a well-established association<sup>
<a href="#B27" class="usa-link" aria-describedby="B27">27</a>
</sup>. A case-control study comparing 50 SLE patients with LN, 50 SLE patients without LN, and 50 healthy controls found a higher prevalence of anxiety and depression among LN patients, with increased risk in those of advanced age and with greater histological activity<sup>
<a href="#B28" class="usa-link" aria-describedby="B28">28</a>
</sup>. Another study investigating the association between psychiatric disorders and PGD involving 950 participants reported a 12% prevalence of psychiatric diagnoses. This diagnosis was significantly associated with CKD progression (HR = 2.45, 95% CI: 1.53–3.92)<sup>
<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
<p>Brazil is a country of continental size, and as such, regional variations in GD patterns are expected. Data from the 2017 Pernambuco Registry of Glomerulopathies the Northeast region reported that FSGS (43.0%) was the most common PGD, while LN (67.0%) was the predominant SGD<sup>
<a href="#B12" class="usa-link" aria-describedby="B12">12</a>
</sup>. A 2015 study in Ceará found nephrotic-range proteinuria in 67.3% of patients, with the most frequent histopathological diagnoses being FSGS (19.6%), MCD (17.9%), MN (16.7%), and LN (11.9%)<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>
</sup>. Similarly, a 2016 survey from Southern Brazil found a higher prevalence of secondary glomerular diseases (61.2%), with LN (30.2%) being the most common diagnosis. Among PGDs, FSGS remained the most frequent (10.3%)<sup>
<a href="#B14" class="usa-link" aria-describedby="B14">14</a>
</sup>. A 2010 study from the Federal District reported FSGS (26.9%) as the most prevalent PGD, while LN (50.0%) was the leading SGD<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>. In Northern Brazil (Amazonas state), FSGS was also identified as the most common GD<sup>
<a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>. A five-year analysis of GD cases in São Paulo, published in the 2006 Paulista Registry of Glomerulopathies, was conducted with data from a multicenter study involving 11 centers that analyzed 1,844 renal biopsies. The most frequent PGDs were FSGS (29.7%), MN (20.7%), and IgAN (17.8%), while LN was the most common SGD (66.2%)<sup>
<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>. The first report of the Brazilian Renal Biopsy Registry was recently published. The study evaluated 954 biopsies, representing all Brazilian regions. The main diagnosis of GD was LN (22.6%), followed by IgAN (13%) and FSGS (12.2%)<sup>
<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>.</p>
<p>In our study, LN remained the most prevalent SGD in our region, corroborating findings from a 2018 international study and other Brazilian studies<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B11" class="usa-link" aria-describedby="B11">11</a>,<a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>,<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. However, in the PGD analysis, FSGS was the third most common diagnosis, along with MCD, after MN and IgAN. This contrasts with previous studies that identified FSGS as the most frequent PGD<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>,<a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>,<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. This finding reflects advances in the understanding of GD pathophysiology, recognizing FSGS not as a single disease but as a histopathological pattern of glomerular injury associated with multiple patholo­gical mechanisms primarily targeting the podocyte<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
<p>Regarding other histopathological findings, our analysis revealed a profile suggestive of advanced chronicity, highlighting the need for earlier kidney biopsy indications, even in cases of persistent glomerular hematuria and/or low-level proteinuria. A Japanese study involving 552,951 participants found hematuria in 26.5%, occasional proteinuria in 10.1%, and persistent proteinuria in 1.5%. Additionally, a decline in eGFR was associated with both isolated hematuria and its synergistic effect with proteinuria<sup>
<a href="#B32" class="usa-link" aria-describedby="B32">32</a>
</sup>.</p>
<p>Throughout follow-up, eGFR declined, while proteinuria levels improved. These findings likely reflect disease progression, with declining eGFR over time, and treatment effects—both immunosuppressive and non-immunosuppressive—on proteinuria evolution. Additional indicators of favorable outcomes include most patients remaining under active follow-up, with low rates of progression to RRT and/or mortality.</p>
<p>Renal survival was highest in MCD and lowest in MPGN. In our study, MCD patients were younger, had lower IFTA and vascular lesion scores, and exhibited higher initial and final eGFR. They also showed greater reductions in proteinuria, suggesting a positive therapeutic response and disease remission. A risk analysis study on CKD progression, RRT requirement, cardiovascular events, and mortality in 907 adults with primary NS (MCD, FSGS, or MN) compared to a healthy control group found lower risks in MCD patients, except for venous thromboembolism<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. MPGN patients in our study had the highest mean age, histological indicators suggestive of chronicity, lower initial and final eGFR, and minimal improvement in proteinuria, indicating a poorer therapeutic response. A Brazilian study analyzing 53 MPGN cases reported partial or complete remission in only 39% of patients<sup>
<a href="#B34" class="usa-link" aria-describedby="B34">34</a>
</sup>.</p>
<p>Renal survival in non-biopsied cases was similar to that of IgAN. A recent study found worse outcomes in IgAN and FSGS, with higher rates of progression to RRT<sup>
<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>. These findings further emphasize the need to reconsider kidney biopsy indications for persistent urinary abnormalities that may not traditionally warrant histopathological evaluation, as well as the importance of expanding genetic analyses<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>,<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>.</p>
<p>The primary factors associated with CKD progression were lower initial eGFR, presence of IFTA, and higher BMI. The association between lower baseline eGFR and worse outcomes may reflect the selection of cases with greater clinical and/or histopathological severity at disease onset. A Korean study analyzing 1,943 renal biopsies from PGD patients found worse disease progression in those with an eGFR below 60 mL/min/1.73m<sup>2,<a href="#B36" class="usa-link" aria-describedby="B36">36</a>
</sup>. Additionally, IFTA severity is a finding classically associated with chronicity and poorer outcomes<sup>
<a href="#B37" class="usa-link" aria-describedby="B37">37</a>
</sup>. Obesity is a well-established risk factor for CKD and has been specifically linked to obesity-associated glomerulopathy<sup>
<a href="#B38" class="usa-link" aria-describedby="B38">38</a>
</sup>. A systematic review and meta-analysis of IgAN cases found that overweight and obese patients had lower eGFR than those with a normal BMI<sup>
<a href="#B39" class="usa-link" aria-describedby="B39">39</a>
</sup>. A Japanese study analyzing 489 LN patients identified BMI and baseline eGFR as independent risk factors for CKD progression<sup>
<a href="#B40" class="usa-link" aria-describedby="B40">40</a>
</sup>.</p>
<p>The main limitations of this study include the extended analysis period, which led to the loss of follow-up of some patients, and constraints in data collection due to its retrospective design, as it was restricted to medical record analysis. Similar to most studies on this topic, our analysis focused on histopathological patterns of glomerular lesions rather than their underlying pathophysiology<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>,<a href="#B11" class="usa-link" aria-describedby="B11">11</a>,<a href="#B12" class="usa-link" aria-describedby="B12">12</a>,<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>,<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>,<a href="#B17" class="usa-link" aria-describedby="B17">17</a>,<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. The next logical step is to evaluate each lesion subgroup, including those not subjected to histological analysis. This additional analysis should incorporate descriptive, analytical, and inferential methods, integrating new clinical, laboratory, and genetic approaches.</p>
<p>In conclusion, LN remained the most prevalent SGD in our region, while FSGS and MCD ranked third among PGDs, after MN and IgAN. Renal survival was highest in MCD and poorest in MPGN. Understanding the epidemiological profile of GD in our environment is crucial for developing health policies aimed at comprehensive care for this specific group of kidney disease patients.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>HU-UFJF/EBSERH Chronic Kidney Disease Com­prehensive Care Unit, UFJF Faculty of Medicine – Juiz de Fora-MG, Brazil.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN2"><p><strong>Funding:</strong> CAPES (Coordination for the Improvement of Higher Education Personnel).</p></div></div></section><section id="sec14"><h2 class="pmc_sec_title">Data Availability</h2>
<p>Data will be shared upon reasonable request to the corresponding author.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305. doi: 10.1056/NEJMoa041031.</cite> [<a href="https://doi.org/10.1056/NEJMoa041031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15385656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Chronic%20kidney%20disease%20and%20the%20risks%20of%20death,%20cardiovascular%20events,%20and%20hospitalization.&amp;author=AS%20Go&amp;author=GM%20Chertow&amp;author=D%20Fan&amp;author=CE%20McCulloch&amp;author=CY%20Hsu&amp;volume=351&amp;issue=13&amp;publication_year=2004&amp;pages=1296-305&amp;pmid=15385656&amp;doi=10.1056/NEJMoa041031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al.  GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. doi: 10.1016/S0140-6736(20)30045-3.</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)30045-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32061315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Global,%20regional,%20and%20national%20burden%20of%20chronic%20kidney%20disease,%201990%E2%80%932017:%20a%20systematic%20analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202017.%20Lancet.&amp;title=GBD%20Chronic%20Kidney%20Disease%20Collaboration.&amp;author=B%20Bikbov&amp;author=CA%20Purcell&amp;author=AS%20Levey&amp;author=M%20Smith&amp;author=A%20Abdoli&amp;volume=395&amp;issue=10225&amp;publication_year=2020&amp;pages=709-33&amp;pmid=32061315&amp;doi=10.1016/S0140-6736(20)30045-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al.  Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765.</cite> [<a href="https://doi.org/10.1371/journal.pone.0158765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4934905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27383068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One.&amp;title=Global%20prevalence%20of%20chronic%20kidney%20disease:%20a%20systematic%20review%20and%20meta-analysis.&amp;author=NR%20Hill&amp;author=ST%20Fatoba&amp;author=JL%20Oke&amp;author=JA%20Hirst&amp;author=CA%20O%E2%80%99Callaghan&amp;volume=11&amp;issue=7&amp;publication_year=2016&amp;pages=e0158765&amp;pmid=27383068&amp;doi=10.1371/journal.pone.0158765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. doi: 10.1016/j.kisu.2021.11.003.</cite> [<a href="https://doi.org/10.1016/j.kisu.2021.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9073222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35529086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Suppl.&amp;title=Epidemiology%20of%20chronic%20kidney%20disease:%20an%20update%202022.&amp;author=CP%20Kovesdy&amp;volume=12&amp;issue=1&amp;publication_year=2022&amp;pages=7-11&amp;pmid=35529086&amp;doi=10.1016/j.kisu.2021.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Nerbass FB, Lima HDN, Moura-Neto JA, Lugon JR, Sesso R. Brazilian dialysis survey 2022. J Bras Nefrol. 2024;46(2):e20230062. doi: 10.1590/2175-8239-jbn-2023-0062en.</cite> [<a href="https://doi.org/10.1590/2175-8239-jbn-2023-0062en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11210532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38078834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bras%20Nefrol.&amp;title=Brazilian%20dialysis%20survey%202022.&amp;author=FB%20Nerbass&amp;author=HDN%20Lima&amp;author=JA%20Moura-Neto&amp;author=JR%20Lugon&amp;author=R%20Sesso&amp;volume=46&amp;issue=2&amp;publication_year=2024&amp;pages=e20230062&amp;pmid=38078834&amp;doi=10.1590/2175-8239-jbn-2023-0062en&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15. doi: 10.1007/978-981-13-8871-2_1.</cite> [<a href="https://doi.org/10.1007/978-981-13-8871-2_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31399958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Exp%20Med%20Biol.&amp;title=Prevalence%20and%20disease%20burden%20of%20chronic%20kidney%20disease.&amp;author=JC%20Lv&amp;author=LX%20Zhang&amp;volume=1165&amp;publication_year=2019&amp;pages=3-15&amp;pmid=31399958&amp;doi=10.1007/978-981-13-8871-2_1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>International Society of Nephrology  . Brussels: ISN; 2021.  [cited 2025 May 7]. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Available from:  <a href="https://kdigo.org/wp-content/uploads/2024/05/KDIGO-2021-Glomerular-Diseases-Guideline_English_2024-Chapter-Updates.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://kdigo.org/wp-content/uploads/2024/05/KDIGO-2021-Glomerular-Diseases-Guideline_English_2024-Chapter-Updates.pdf</a>
.</cite> [<a href="https://scholar.google.com/scholar_lookup?International%20Society%20of%20Nephrology%20.%20Brussels:%20ISN;%202021.%20%5Bcited%202025%20May%207%5D.%20KDIGO%202021%20clinical%20practice%20guideline%20for%20the%20management%20of%20glomerular%20diseases.%20Available%20from:%20https://kdigo.org/wp-content/uploads/2024/05/KDIGO-2021-Glomerular-Diseases-Guideline_English_2024-Chapter-Updates.pdf%20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387(10032):2036–48. doi: 10.1016/S0140-6736(16)00272-5.</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)00272-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26921911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;title=Primary%20glomerulonephritides.&amp;author=J%20Floege&amp;author=K%20Amann&amp;volume=387&amp;issue=10032&amp;publication_year=2016&amp;pages=2036-48&amp;pmid=26921911&amp;doi=10.1016/S0140-6736(16)00272-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Guo Q, Wu S, Xu C, Wang J, Chen J. Global disease burden from acute glomerulonephritis 1990-2019. Kidney Int Rep. 2021;6(8):2212–7. doi: 10.1016/j.ekir.2021.04.038.</cite> [<a href="https://doi.org/10.1016/j.ekir.2021.04.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8343788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34386671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Rep.&amp;title=Global%20disease%20burden%20from%20acute%20glomerulonephritis%201990-2019.&amp;author=Q%20Guo&amp;author=S%20Wu&amp;author=C%20Xu&amp;author=J%20Wang&amp;author=J%20Chen&amp;volume=6&amp;issue=8&amp;publication_year=2021&amp;pages=2212-7&amp;pmid=34386671&amp;doi=10.1016/j.ekir.2021.04.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>O’Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant. 2018;33(4):661–9. doi: 10.1093/ndt/gfx189.</cite> [<a href="https://doi.org/10.1093/ndt/gfx189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6659026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29106637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant.&amp;title=Glomerular%20disease%20frequencies%20by%20race,%20sex%20and%20region:%20results%20from%20the%20International%20Kidney%20Biopsy%20Survey.&amp;author=MM%20O%E2%80%99Shaughnessy&amp;author=SL%20Hogan&amp;author=BD%20Thompson&amp;author=R%20Coppo&amp;author=AB%20Fogo&amp;volume=33&amp;issue=4&amp;publication_year=2018&amp;pages=661-9&amp;pmid=29106637&amp;doi=10.1093/ndt/gfx189&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Polito MG, de Moura LA, Kirsztajn GM. An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transplant. 2010;25(2):490–6. doi: 10.1093/ndt/gfp355.</cite> [<a href="https://doi.org/10.1093/ndt/gfp355" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19633091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant.&amp;title=An%20overview%20on%20frequency%20of%20renal%20biopsy%20diagnosis%20in%20Brazil:%20clinical%20and%20pathological%20patterns%20based%20on%209,617%20native%20kidney%20biopsies.&amp;author=MG%20Polito&amp;author=LA%20de%20Moura&amp;author=GM%20Kirsztajn&amp;volume=25&amp;issue=2&amp;publication_year=2010&amp;pages=490-6&amp;pmid=19633091&amp;doi=10.1093/ndt/gfp355&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Costa DM, Valente LM, Gouveia PA, Sarinho FW, Fernandes GV, Cavalcante MA, et al.  Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies - REPEG. J Bras Nefrol. 2017;39(1):29–35. doi: 10.5935/0101-2800.20170005.</cite> [<a href="https://doi.org/10.5935/0101-2800.20170005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28355399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bras%20Nefrol.&amp;title=Comparative%20analysis%20of%20primary%20and%20secondary%20glomerulopathies%20in%20the%20northeast%20of%20Brazil:%20data%20from%20the%20Pernambuco%20Registry%20of%20Glomerulopathies%20-%20REPEG.&amp;author=DM%20Costa&amp;author=LM%20Valente&amp;author=PA%20Gouveia&amp;author=FW%20Sarinho&amp;author=GV%20Fernandes&amp;volume=39&amp;issue=1&amp;publication_year=2017&amp;pages=29-35&amp;pmid=28355399&amp;doi=10.5935/0101-2800.20170005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Queiroz AL, Barreto DM, Silva GB, Jr, Tavares No JE, Costa FI, Patrocínio RM, et al.  Pattern, clinical features and response to corticoids of glomerular diseases in a Brazilian population: an analytical cross-sectional study. Sao Paulo Med J. 2015;133(1):43-50. doi: 10.1590/1516-3180.2013.7360006.</cite> [<a href="https://doi.org/10.1590/1516-3180.2013.7360006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10496615/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25424774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sao%20Paulo%20Med%20J.&amp;title=Pattern,%20clinical%20features%20and%20response%20to%20corticoids%20of%20glomerular%20diseases%20in%20a%20Brazilian%20population:%20an%20analytical%20cross-sectional%20study.&amp;author=AL%20Queiroz&amp;author=DM%20Barreto&amp;author=GB%20Silva&amp;author=JE%20Tavares%20No&amp;author=FI%20Costa&amp;volume=133&amp;issue=1&amp;publication_year=2015&amp;pages=43-50&amp;pmid=25424774&amp;doi=10.1590/1516-3180.2013.7360006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Crensiglova C, Rehme BB, Kinasz LR, Chula DC, Nascimento MM, Soares MF. Frequency and clinical histological analysis of glomerular diseases in a tertiary hospital in southern Brazil. J Bras Nefrol. 2016;38(1):42–8. doi: 10.5935/0101-2800.20160007.</cite> [<a href="https://doi.org/10.5935/0101-2800.20160007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27049363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bras%20Nefrol.&amp;title=Frequency%20and%20clinical%20histological%20analysis%20of%20glomerular%20diseases%20in%20a%20tertiary%20hospital%20in%20southern%20Brazil.&amp;author=C%20Crensiglova&amp;author=BB%20Rehme&amp;author=LR%20Kinasz&amp;author=DC%20Chula&amp;author=MM%20Nascimento&amp;volume=38&amp;issue=1&amp;publication_year=2016&amp;pages=42-8&amp;pmid=27049363&amp;doi=10.5935/0101-2800.20160007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Ferraz FHRP, Martins CGB, Cavalcanti JC, Oliveira FL, Quirino RM, Chicon R, et al.  Profile of glomerular diseases in a public hospital of Federal District, Brazil. J Bras Nefrol. 2010;32(3):249–56. doi: 10.1590/S0101-28002010000300005.</cite> [<a href="https://doi.org/10.1590/S0101-28002010000300005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21103687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bras%20Nefrol.&amp;title=Profile%20of%20glomerular%20diseases%20in%20a%20public%20hospital%20of%20Federal%20District,%20Brazil.&amp;author=FHRP%20Ferraz&amp;author=CGB%20Martins&amp;author=JC%20Cavalcanti&amp;author=FL%20Oliveira&amp;author=RM%20Quirino&amp;volume=32&amp;issue=3&amp;publication_year=2010&amp;pages=249-56&amp;pmid=21103687&amp;doi=10.1590/S0101-28002010000300005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Cardoso ACD, Kirsztajn GM. Padrões histopatológicos das doenças glomerulares no Amazonas.  [cited 2025 May 7];Braz J Nephrol. 2006 28(1):39–43. Available from:  <a href="https://bjnephrology.org/wp-content/uploads/2019/11/jbn_v28n1a07.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://bjnephrology.org/wp-content/uploads/2019/11/jbn_v28n1a07.pdf</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Braz%20J%20Nephrol.&amp;title=Padr%C3%B5es%20histopatol%C3%B3gicos%20das%20doen%C3%A7as%20glomerulares%20no%20Amazonas.&amp;author=ACD%20Cardoso&amp;author=GM%20Kirsztajn&amp;volume=28&amp;issue=1&amp;publication_year=2006&amp;pages=39-43&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Malafronte P, Mastroianni-Kirsztajn G, Betônico GN, Romão JE, Jr, Alves MA, Carvalho MF, et al.  Paulista Registry of glomerulonephritis: 5-year data report. Nephrol Dial Transplant. 2006;21(11):3098–105. doi: 10.1093/ndt/gfl237.</cite> [<a href="https://doi.org/10.1093/ndt/gfl237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16968733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant.&amp;title=Paulista%20Registry%20of%20glomerulonephritis:%205-year%20data%20report.&amp;author=P%20Malafronte&amp;author=G%20Mastroianni-Kirsztajn&amp;author=GN%20Bet%C3%B4nico&amp;author=JE%20Rom%C3%A3o&amp;author=MA%20Alves&amp;volume=21&amp;issue=11&amp;publication_year=2006&amp;pages=3098-105&amp;pmid=16968733&amp;doi=10.1093/ndt/gfl237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Carmo PAV, Carmo WB, Bastos MG, Andrade LCF. Estudo das doenças glomerulares na Zona da Mata Mineira.  [cited 2025 May 7];Braz J Nephrol. 2008 30(1):15–21. Available from:  <a href="https://bjnephrology.org/wp-content/uploads/2019/11/jbn_v28n1a07.pdf.https://bjnephrology.org/wp-content/uploads/2019/08/jbn_v30n1a4.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://bjnephrology.org/wp-content/uploads/2019/11/jbn_v28n1a07.pdf. https://bjnephrology.org/wp-content/uploads/2019/08/jbn_v30n1a4.pdf</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Braz%20J%20Nephrol&amp;title=Estudo%20das%20doen%C3%A7as%20glomerulares%20na%20Zona%20da%20Mata%20Mineira.&amp;author=PAV%20Carmo&amp;author=WB%20Carmo&amp;author=MG%20Bastos&amp;author=LCF%20Andrade&amp;volume=30&amp;issue=1&amp;publication_year=2008&amp;pages=15-21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Srikantharajah M, McAdoo S. Secondary glomerular disease. Medicine. 2023;51(4):252–7. doi: 10.1016/j.mpmed.2023.01.003.</cite> [<a href="https://doi.org/10.1016/j.mpmed.2023.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine.&amp;title=Secondary%20glomerular%20disease.&amp;author=M%20Srikantharajah&amp;author=S%20McAdoo&amp;volume=51&amp;issue=4&amp;publication_year=2023&amp;pages=252-7&amp;doi=10.1016/j.mpmed.2023.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al.  New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49. doi: 10.1056/NEJMoa2102953.</cite> [<a href="https://doi.org/10.1056/NEJMoa2102953" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8822996/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34554658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=New%20creatinine-%20and%20cystatin%20C-based%20equations%20to%20estimate%20GFR%20without%20race.&amp;author=LA%20Inker&amp;author=ND%20Eneanya&amp;author=J%20Coresh&amp;author=H%20Tighiouart&amp;author=D%20Wang&amp;volume=385&amp;issue=19&amp;publication_year=2021&amp;pages=1737-49&amp;pmid=34554658&amp;doi=10.1056/NEJMoa2102953&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene. 2018;668:59–72. doi: 10.1016/j.gene.2018.05.041.</cite> [<a href="https://doi.org/10.1016/j.gene.2018.05.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29775752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gene.&amp;title=The%20genetics%20and%20molecular%20pathogenesis%20of%20systemic%20lupus%20erythematosus%20(SLE)%20in%20populations%20of%20different%20ancestry.&amp;author=GN%20Goulielmos&amp;author=MI%20Zervou&amp;author=VM%20Vazgiourakis&amp;author=Y%20Ghodke-Puranik&amp;author=A%20Garyfallos&amp;volume=668&amp;publication_year=2018&amp;pages=59-72&amp;pmid=29775752&amp;doi=10.1016/j.gene.2018.05.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al.  Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380(2):142–51. doi: 10.1056/NEJMoa1806891.</cite> [<a href="https://doi.org/10.1056/NEJMoa1806891" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6510541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Diagnostic%20utility%20of%20exome%20sequencing%20for%20kidney%20disease.&amp;author=EE%20Groopman&amp;author=M%20Marasa&amp;author=S%20Cameron-Christie&amp;author=S%20Petrovski&amp;author=VS%20Aggarwal&amp;volume=380&amp;issue=2&amp;publication_year=2019&amp;pages=142-51&amp;pmid=30586318&amp;doi=10.1056/NEJMoa1806891&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Vairo FP, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, et al.  Genomics Integration Into Nephrology Practice. Kidney Med. 2021;3(5):785–98. doi: 10.1016/j.xkme.2021.04.014.</cite> [<a href="https://doi.org/10.1016/j.xkme.2021.04.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8551494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34746741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Med.&amp;title=Genomics%20Integration%20Into%20Nephrology%20Practice.&amp;author=FP%20Vairo&amp;author=C%20Prochnow&amp;author=JL%20Kemppainen&amp;author=EC%20Lisi&amp;author=JM%20Steyermark&amp;volume=3&amp;issue=5&amp;publication_year=2021&amp;pages=785-98&amp;pmid=34746741&amp;doi=10.1016/j.xkme.2021.04.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Landini S, Mazzinghi B, Becherucci F, Allinovi M, Provenzano A, Palazzo V, et al.  Reverse phenotyping after whole-exome sequencing in steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2020;15(1):89–100. doi: 10.2215/CJN.06060519.</cite> [<a href="https://doi.org/10.2215/CJN.06060519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6946071/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31831576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol.&amp;title=Reverse%20phenotyping%20after%20whole-exome%20sequencing%20in%20steroid-resistant%20nephrotic%20syndrome.&amp;author=S%20Landini&amp;author=B%20Mazzinghi&amp;author=F%20Becherucci&amp;author=M%20Allinovi&amp;author=A%20Provenzano&amp;volume=15&amp;issue=1&amp;publication_year=2020&amp;pages=89-100&amp;pmid=31831576&amp;doi=10.2215/CJN.06060519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Canney M, Gunning HM, Zheng Y, Rose C, Jauhal A, Hur SA, et al.  The risk of cardiovascular events in individuals with primary glomerular diseases. Am J Kidney Dis. 2022;80(6):740–50. doi: 10.1053/j.ajkd.2022.04.005.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2022.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35659570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis.&amp;title=The%20risk%20of%20cardiovascular%20events%20in%20individuals%20with%20primary%20glomerular%20diseases.&amp;author=M%20Canney&amp;author=HM%20Gunning&amp;author=Y%20Zheng&amp;author=C%20Rose&amp;author=A%20Jauhal&amp;volume=80&amp;issue=6&amp;publication_year=2022&amp;pages=740-50&amp;pmid=35659570&amp;doi=10.1053/j.ajkd.2022.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Hermansen ML, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study. Rheumatology. 2017;56(5):709–15. doi: 10.1093/rheumatology/kew475.</cite> [<a href="https://doi.org/10.1093/rheumatology/kew475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28053276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology.&amp;title=The%20risk%20of%20cardiovascular%20morbidity%20and%20cardiovascular%20mortality%20in%20systemic%20lupus%20erythematosus%20and%20lupus%20nephritis:%20a%20Danish%20nationwide%20population-based%20cohort%20study.&amp;author=ML%20Hermansen&amp;author=J%20Lindhardsen&amp;author=C%20Torp-Pedersen&amp;author=M%20Faurschou&amp;author=S%20Jacobsen&amp;volume=56&amp;issue=5&amp;publication_year=2017&amp;pages=709-15&amp;pmid=28053276&amp;doi=10.1093/rheumatology/kew475&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–7. doi: 10.4065/81.10.1361.</cite> [<a href="https://doi.org/10.4065/81.10.1361" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17036562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc.&amp;title=Psychiatric%20adverse%20effects%20of%20corticosteroids.&amp;author=TP%20Warrington&amp;author=JM%20Bostwick&amp;volume=81&amp;issue=10&amp;publication_year=2006&amp;pages=1361-7&amp;pmid=17036562&amp;doi=10.4065/81.10.1361&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Hu Y, Zhan G. Anxiety and depression prevalence and their risk factors in lupus nephritis patients: a case-control study. Immun Inflamm Dis. 2022;10(9):e689. doi: 10.1002/iid3.689.</cite> [<a href="https://doi.org/10.1002/iid3.689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9394231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36039650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immun%20Inflamm%20Dis.&amp;title=Anxiety%20and%20depression%20prevalence%20and%20their%20risk%20factors%20in%20lupus%20nephritis%20patients:%20a%20case-control%20study.&amp;author=Y%20Hu&amp;author=G%20Zhan&amp;volume=10&amp;issue=9&amp;publication_year=2022&amp;pages=e689&amp;pmid=36039650&amp;doi=10.1002/iid3.689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Desmond HE, Lindner C, Troost JP, Held Z, Callaway A, Oh GJ, et al.  Association between Psychiatric Disorders and Glomerular Disease. Glomerular Dis. 2021;1(3):118–28. doi: 10.1159/000516359.</cite> [<a href="https://doi.org/10.1159/000516359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9677713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36751494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glomerular%20Dis.&amp;title=Association%20between%20Psychiatric%20Disorders%20and%20Glomerular%20Disease.&amp;author=HE%20Desmond&amp;author=C%20Lindner&amp;author=JP%20Troost&amp;author=Z%20Held&amp;author=A%20Callaway&amp;volume=1&amp;issue=3&amp;publication_year=2021&amp;pages=118-28&amp;pmid=36751494&amp;doi=10.1159/000516359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Noronha IL, Ramalho RJ, Oliveira CMC, Bahiense-Oliveira M, Barbosa FAM, Barros No, JR, et al.  Implementation and first report of the Brazilian Kidney Biopsy Registry. PLoS One. 2025;20(2):e0312410. doi: 10.1371/journal.pone.0312410.</cite> [<a href="https://doi.org/10.1371/journal.pone.0312410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11809849/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39928634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One.&amp;title=Implementation%20and%20first%20report%20of%20the%20Brazilian%20Kidney%20Biopsy%20Registry.&amp;author=IL%20Noronha&amp;author=RJ%20Ramalho&amp;author=CMC%20Oliveira&amp;author=M%20Bahiense-Oliveira&amp;author=FAM%20Barbosa&amp;volume=20&amp;issue=2&amp;publication_year=2025&amp;pages=e0312410&amp;pmid=39928634&amp;doi=10.1371/journal.pone.0312410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11(2):76–87. doi: 10.1038/nrneph.2014.216.</cite> [<a href="https://doi.org/10.1038/nrneph.2014.216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4772430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25447132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol.&amp;title=Causes%20and%20pathogenesis%20of%20focal%20segmental%20glomerulosclerosis.&amp;author=AB%20Fogo&amp;volume=11&amp;issue=2&amp;publication_year=2015&amp;pages=76-87&amp;pmid=25447132&amp;doi=10.1038/nrneph.2014.216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Tasaki H, Eriguchi M, Yoshida H, Uemura T, Fukata F, Nishimoto M, et al.  Synergistic effect of proteinuria on dipstick hematuria-related decline in kidney function: the Japan Specific Health Checkups (J-SHC) study. Clin Exp Nephrol. 2023;27(12):990–1000. doi: 10.1007/s10157-023-02390-6.</cite> [<a href="https://doi.org/10.1007/s10157-023-02390-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37603115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Nephrol.&amp;title=Synergistic%20effect%20of%20proteinuria%20on%20dipstick%20hematuria-related%20decline%20in%20kidney%20function:%20the%20Japan%20Specific%20Health%20Checkups%20(J-SHC)%20study.&amp;author=H%20Tasaki&amp;author=M%20Eriguchi&amp;author=H%20Yoshida&amp;author=T%20Uemura&amp;author=F%20Fukata&amp;volume=27&amp;issue=12&amp;publication_year=2023&amp;pages=990-1000&amp;pmid=37603115&amp;doi=10.1007/s10157-023-02390-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Go AS, Tan TC, Chertow GM, Ordonez JD, Fan D, Law D, et al.  Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the kaiser permanente nephrotic syndrome study. J Am Soc Nephrol. 2021;32(9):2303–14. doi: 10.1681/ASN.2020111583.</cite> [<a href="https://doi.org/10.1681/ASN.2020111583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8729848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34362836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Soc%20Nephrol.&amp;title=Primary%20nephrotic%20syndrome%20and%20risks%20of%20ESKD,%20cardiovascular%20events,%20and%20death:%20the%20kaiser%20permanente%20nephrotic%20syndrome%20study.&amp;author=AS%20Go&amp;author=TC%20Tan&amp;author=GM%20Chertow&amp;author=JD%20Ordonez&amp;author=D%20Fan&amp;volume=32&amp;issue=9&amp;publication_year=2021&amp;pages=2303-14&amp;pmid=34362836&amp;doi=10.1681/ASN.2020111583&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Bernardes TP, Mastroianni-Kirsztajn G. Membranoproliferative glomerulonephritis: current histopathological classification, clinical profile, and kidney outcomes. J Bras Nefrol. 2023;45(1):45–50. doi: 10.1590/2175-8239-jbn-2022-0016pt.</cite> [<a href="https://doi.org/10.1590/2175-8239-jbn-2022-0016pt" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10139719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35789244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Bras%20Nefrol.&amp;title=Membranoproliferative%20glomerulonephritis:%20current%20histopathological%20classification,%20clinical%20profile,%20and%20kidney%20outcomes.&amp;author=TP%20Bernardes&amp;author=G%20Mastroianni-Kirsztajn&amp;volume=45&amp;issue=1&amp;publication_year=2023&amp;pages=45-50&amp;pmid=35789244&amp;doi=10.1590/2175-8239-jbn-2022-0016pt&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Abd ElHafeez S, Kramer A, Arici M, Arnol M, Åsberg A, Bell S, et al.  Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry. Nephrol Dial Transplant. 2024;39(9):1449–60. doi: 10.1093/ndt/gfae034.</cite> [<a href="https://doi.org/10.1093/ndt/gfae034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11483622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38327216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant.&amp;title=Incidence%20and%20outcomes%20of%20kidney%20replacement%20therapy%20for%20end-stage%20kidney%20disease%20due%20to%20primary%20glomerular%20disease%20in%20Europe:%20findings%20from%20the%20ERA%20Registry.&amp;author=S%20Abd%20ElHafeez&amp;author=A%20Kramer&amp;author=M%20Arici&amp;author=M%20Arnol&amp;author=A%20%C3%85sberg&amp;volume=39&amp;issue=9&amp;publication_year=2024&amp;pages=1449-60&amp;pmid=38327216&amp;doi=10.1093/ndt/gfae034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, et al.  Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol. 2013;37(1):74–83. doi: 10.1159/000345960.</cite> [<a href="https://doi.org/10.1159/000345960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23343855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Nephrol.&amp;title=Mortality%20and%20renal%20outcome%20of%20primary%20glomerulonephritis%20in%20Korea:%20observation%20in%201,943%20biopsied%20cases.&amp;author=H%20Lee&amp;author=DK%20Kim&amp;author=KH%20Oh&amp;author=KW%20Joo&amp;author=YS%20Kim&amp;volume=37&amp;issue=1&amp;publication_year=2013&amp;pages=74-83&amp;pmid=23343855&amp;doi=10.1159/000345960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Wilson PC, Kashgarian M, Moeckel G. Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis. Clin Kidney J. 2018;11(2):207–18. doi: 10.1093/ckj/sfx093.</cite> [<a href="https://doi.org/10.1093/ckj/sfx093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5888814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29644061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Kidney%20J.&amp;title=Interstitial%20inflammation%20and%20interstitial%20fibrosis%20and%20tubular%20atrophy%20predict%20renal%20survival%20in%20lupus%20nephritis.&amp;author=PC%20Wilson&amp;author=M%20Kashgarian&amp;author=G%20Moeckel&amp;volume=11&amp;issue=2&amp;publication_year=2018&amp;pages=207-18&amp;pmid=29644061&amp;doi=10.1093/ckj/sfx093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>D’Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, et al.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–71. doi: 10.1038/nrneph.2016.75.</cite> [<a href="https://doi.org/10.1038/nrneph.2016.75" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27263398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol.&amp;title=Obesity-related%20glomerulopathy:%20clinical%20and%20pathologic%20characteristics%20and%20pathogenesis.&amp;author=VD%20D%E2%80%99Agati&amp;author=A%20Chagnac&amp;author=AP%20de%20Vries&amp;author=M%20Levi&amp;author=E%20Porrini&amp;volume=12&amp;issue=8&amp;publication_year=2016&amp;pages=453-71&amp;pmid=27263398&amp;doi=10.1038/nrneph.2016.75&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Kanbay M, Yildiz AB, Yavuz F, Covic A, Ortiz A, Siriopol D. The role of body mass index on IgA nephropathy prognosis: a systematic review and meta-analysis. Int Urol Nephrol. 2022;54(10):2567–79. doi: 10.1007/s11255-022-03160-1.</cite> [<a href="https://doi.org/10.1007/s11255-022-03160-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35278147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Urol%20Nephrol.&amp;title=The%20role%20of%20body%20mass%20index%20on%20IgA%20nephropathy%20prognosis:%20a%20systematic%20review%20and%20meta-analysis.&amp;author=M%20Kanbay&amp;author=AB%20Yildiz&amp;author=F%20Yavuz&amp;author=A%20Covic&amp;author=A%20Ortiz&amp;volume=54&amp;issue=10&amp;publication_year=2022&amp;pages=2567-79&amp;pmid=35278147&amp;doi=10.1007/s11255-022-03160-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Ikeuchi H, Sugiyama H, Sato H, Yokoyama H, Maruyama S, Mukoyama M, et al.  A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan. Clin Exp Nephrol. 2022;26(9):898–908. doi: 10.1007/s10157-022-02232-x.</cite> [<a href="https://doi.org/10.1007/s10157-022-02232-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35556186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Nephrol.&amp;title=A%20nationwide%20analysis%20of%20renal%20and%20patient%20outcomes%20for%20adults%20with%20lupus%20nephritis%20in%20Japan.&amp;author=H%20Ikeuchi&amp;author=H%20Sugiyama&amp;author=H%20Sato&amp;author=H%20Yokoyama&amp;author=S%20Maruyama&amp;volume=26&amp;issue=9&amp;publication_year=2022&amp;pages=898-908&amp;pmid=35556186&amp;doi=10.1007/s10157-022-02232-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" lang="pt" id="s1"><section class="pmc-layout__citation font-secondary font-xs"><div>J Bras Nefrol. 2025 Aug 15;47(4):e20240213. [Article in Portuguese] doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2024-0213pt" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2024-0213pt</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Perfil epidemiológico e desfechos renais em uma coorte Brasileira de 25 anos de doenças glomerulares</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sales%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Fernando Sales</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Fernando Sales</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Concepção, Curadoria de dados, Investigação, Metodologia, Redação – rascunho original</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sales%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fernando Sales</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carmo%20PVD%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Priscylla Vieira do Carmo</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Priscylla Vieira do Carmo</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Curadoria de dados</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carmo%20PVD%22%5BAuthor%5D" class="usa-link"><span class="name western">Priscylla Vieira do Carmo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huaira%20RMNH%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Rosália Maria Nunes Henriques Huaira</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Análise formal, Visualização</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huaira%20RMNH%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almeida%20NWGD%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Nicolas William Gonçalves de Almeida</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Nicolas William Gonçalves de Almeida</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Curadoria de dados</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almeida%20NWGD%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicolas William Gonçalves de Almeida</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louren%C3%A7o%20MHT%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Mateus Henrique Toledo Lourenço</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Mateus Henrique Toledo Lourenço</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Curadoria de dados</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louren%C3%A7o%20MHT%22%5BAuthor%5D" class="usa-link"><span class="name western">Mateus Henrique Toledo Lourenço</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20NMDS%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Natália Maria da Silva Fernandes</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Natália Maria da Silva Fernandes</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div>Concepção, Análise formal, Metodologia, Supervisão, Validação, Visualização, Redação – revisão e edição</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20NMDS%22%5BAuthor%5D" class="usa-link"><span class="name western">Natália Maria da Silva Fernandes</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a.c" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<div class="p" id="aff2">
<sup>1</sup>Universidade Federal de Juíz de Fora, Hospital Universitário, Juiz de Fora, MG, Brasil.</div>
<div class="author-notes p">
<div class="fn" id="c002">
<sup>✉</sup><p class="display-inline">
<strong>Correspondência para:</strong> Fernando Sales. E-mail: <span>fernansales@gmail.com</span>
</p>
</div>
<div class="fn" id="fn8"><p><strong>Conflito de Interesse:</strong> Os autores declaram não haver conflito de interesse.</p></div>
<div class="fn" id="FN3">
<p><strong>Responsabilidade Editorial:</strong> Editor-chefe: Miguel C. Riella <a href="https://orcid.org/0000-0003-4181-613X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-4181-613X</a>.</p>
<p>Editor Associado: Luis Martin <a href="https://orcid.org/0000-0003-1435-7994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-1435-7994</a>.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Fernando Sales</span></strong>: <span class="role">Concepção, Curadoria de dados, Investigação, Metodologia, Redação – rascunho original</span>
</div>
<div>
<strong class="contrib"><span class="name western">Priscylla Vieira do Carmo</span></strong>: <span class="role">Curadoria de dados</span>
</div>
<div>
<strong class="contrib"><span class="name western">Rosália Maria Nunes Henriques Huaira</span></strong>: <span class="role">Análise formal, Visualização</span>
</div>
<div>
<strong class="contrib"><span class="name western">Nicolas William Gonçalves de Almeida</span></strong>: <span class="role">Curadoria de dados</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mateus Henrique Toledo Lourenço</span></strong>: <span class="role">Curadoria de dados</span>
</div>
<div>
<strong class="contrib"><span class="name western">Natália Maria da Silva Fernandes</span></strong>: <span class="role">Concepção, Análise formal, Metodologia, Supervisão, Validação, Visualização, Redação – revisão e edição</span>
</div>
</div>
<div id="anp_a.c" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub1" class="history"><p>Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><section class="abstract" id="abstract2"><h2>Resumo</h2>
<section id="sec15"><h3 class="pmc_sec_title">Introdução:</h3>
<p>Doenças glomerulares (DG) constituem importante causa de doença renal crônica (DRC). Este estudo teve como objetivo analisar perfis sociodemográfico, clínico e de desfechos renais em pacientes com DG.</p></section><section id="sec16"><h3 class="pmc_sec_title">Métodos:</h3>
<p>Realizou-se estudo de coorte retrospectivo entre 1998–2023, com pacientes com idade ≥ 18 anos, diagnosticados com DG e atendidos em um hospital universitário no Brasil. Foram analisadas variáveis sociodemográficas, clínicas, histopatológicas e renais. Realizada análise comparativa entre os diagnósticos histopatológicos mais frequentes. A variável de desfecho foi a sobrevida renal.</p></section><section id="sec17"><h3 class="pmc_sec_title">Resultados:</h3>
<p>Foram avaliados 417 pacientes, 57,3% eram mulheres e 69,8% brancos. A idade média foi 41,7 ± 14,4 anos. Doenças glomerulares primárias (DGP) representaram 51,1%, e 77,5% dos pacientes foram submetidos à biópsia renal. A DGP mais frequente foi nefropatia membranosa (26,3%), enquanto, entre as doenças glomerulares secundárias (DGS), nefrite lúpica (NL) foi a mais comum (51,9%). Doença de lesão mínima associou-se a melhor sobrevida renal, enquanto glomerulonefrite membra­noproliferativa apresentou piores desfechos (p = 0,001). Com relação à progressão da DRC, taxa de filtração glomerular estimada (TFGe) inicial maior foi fator de proteção (HR = 0,956, IC95%: 0,920–0,994; p = 0,023), ao passo que a presença de fibrose intersticial/atrofia tubular (FIAT) (HR = 1,079, IC95%: 1,020–1,142; p = 0,008) e índice de massa corporal (IMC) mais alto (HR = 1,257, IC95%: 1,016–1,556; p = 0,035) foram associados a um risco aumentado de progressão da DRC.</p></section><section id="sec18"><h3 class="pmc_sec_title">Conclusão:</h3>
<p>A NL manteve-se como a DGS mais comum em nossa região, enquanto a glomeruloesclerose segmentar e focal foi a terceira DGP mais comum. Fatores de risco para piores desfechos incluíram maior IMC, menor TFGe e maior FIAT.</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Descritores:</strong> Estudos de Coortes, Insuficiência Renal Crônica, Epidemiologia, Glomerulonefrite, Patologia</p></section></section><section id="sec19"><h2 class="pmc_sec_title">Introdução</h2>
<p>A doença renal crônica (DRC) é considerada um dos maiores desafios de saúde pública em todo o mundo, além de ser um fator de risco independente para doenças cardiovasculares (DCV)<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup>. A prevalência global estimada da DRC, referente aos cinco estágios da doença, é de 13,4% (11,7–15,1%) e afeta mais de 800 milhões de pessoas<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B4" class="usa-link" aria-describedby="B4">4</a>
</sup>. No Brasil, a prevalência nacional de pacientes em diálise crônica aumentou de 665 por milhão de habitantes em 2019 para 758 em 2022<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>.</p>
<p>As doenças glomerulares (DG) representam a terceira principal causa de DRC dialítica no Brasil e em diversos outros países, atrás apenas da hipertensão arterial sistêmica (HAS) e do diabetes mellitus (DM)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B6" class="usa-link" aria-describedby="B6">6</a>
</sup>. Essas condições compreendem um grupo heterogêneo de distúrbios associados à elevada morbidade e mortalidade e a um impacto socioeconômico significativo, dado seu papel como a mais frequente causa de DRC dependente de diálise em adultos jovens<sup>
<a href="#B6" class="usa-link" aria-describedby="B6">6</a>–<a href="#B9" class="usa-link" aria-describedby="B9">9</a>
</sup>.</p>
<p>Um estudo multicêntrico internacional realizado em 2018 analisou 42.603 biópsias de rins nativos provenientes de 29 centros de nefrologia em todo o mundo. Na América Latina, os diagnósticos mais prevalentes foram a nefrite lúpica (NL) (38,1%) e a glomeruloesclerose segmentar e focal (GESF) (15,8%)<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>.</p>
<p>Em 2010, uma pesquisa nacional sobre DG no Brasil incluiu 9.617 biópsias renais e relatou que a maioria dos pacientes era branca (72,0%), do sexo feminino (51,0%) e oriunda da região Sudeste (47,0%), com idade média de 35,07 ± 18,22 anos. A principal indicação para biópsia foi a síndrome nefrótica (SN) (39,0%) e a injúria renal aguda (IRA) esteve presente em 14,4% dos casos<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>
</sup>. A NL (45,5%) foi a doença glomerular secundária (DGS) mais comum, ao passo que a GESF (24,6%) foi a doença glomerular primária (DGP)<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>
</sup> mais frequente, com achado semelhante descrito em diversos estudos regionais brasileiros anteriores<sup>
<a href="#B12" class="usa-link" aria-describedby="B12">12</a>–<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>.</p>
<p>O Hospital Universitário da Universidade Federal de Juiz de Fora (HU/UFJF) presta atendimento nefrológico a pacientes de diversos municípios da região da Zona da Mata Mineira. O ambulatório de DG do hospital atua como um centro de referência para toda a região. Um estudo anterior, publicado em 2008, examinou o perfil epidemiológico das DG na região da Zona da Mata Mineira, com análise de 126 biópsias de rins nativos de pacientes adultos entre 1996 e 2006. A apresentação clínica mais comum foi a SN (55,2%), enquanto os diagnósticos histopatológicos mais frequentes foram a GESF (40,8%) entre as DGP, e a NL (80,7%) entre as secundárias<sup>
<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>.</p>
<p>A última avaliação dessa população foi realizada há 19 anos, a qual revelou um perfil epidemiológico que aparenta ter se modificado ao longo do tempo. Assim, o presente estudo teve como objetivo realizar uma nova análise dos padrões de DG, identificar as apresentações clínicas e histopatológicas predo­minantes, bem como avaliar os fatores associados à progressão e aos desfechos da doença renal.</p></section><section id="sec20"><h2 class="pmc_sec_title">Métodos</h2>
<p>Foi realizado um estudo de coorte retrospectivo de janeiro de 1998 a janeiro de 2023. A amostra foi composta por pacientes adultos atendidos no ambulatório de DG do Departamento de Nefrologia da UFJF. Os critérios de inclusão foram um diagnóstico confirmado de DG (com ou sem biópsia renal) e idade ≥18 anos. Os critérios de exclusão foram: diagnóstico de DG em estágio avançado (glomerulonefrite crônica), terapia renal substitutiva (TRS) em curso ou histórico de transplante renal. A glomerulonefrite crônica foi definida como uma perda grave da função renal (TFGe &lt; 20–30 mL/min por 1,73 m<sup>2</sup>) associada a danos renais extensos e irreversíveis (principalmente fibrose intersticial e atrofia tubular avançadas e/ou atrofia renal bilateral), nos quais nenhuma abordagem terapêutica em andamento poderia razoavelmente alterar o curso natural do declínio da função renal<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>
</sup>.</p>
<p>Os dados foram coletados dos registros médicos dos pacientes, com variáveis categorizadas de acordo com a admissão, o acompanhamento e o término do seguimento. Foram extraídos dados sociodemográficos, clínicos, laboratoriais, histopa­tológicos e de desfechos renais.</p>
<p>As seguintes variáveis foram analisadas: variáveis de admissão (dados sociodemográficos, comorbidades associadas, histórico social e familiar de nefropatia, apresentação nefrológica inicial e classificação da DG como primária ou secundária<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>) e variáveis de biópsia (idade na biópsia, número de biópsias realizadas, diagnóstico e características histopatológicas).</p>
<p>As DGS são definidas como distúrbios glomeru­lares com causa subjacente ou sistêmica identificável, como infecções, doenças autoimunes e reumáticas (por exemplo, lúpus eritematoso sistêmico e vasculites de pequenos vasos), lesões glomerulares induzidas por medicamentos (sejam diretas ou mediadas por autoimunidade) e neoplasias, como tumores sólidos e malignidades hematológicas. Em contraste, as DGP são caracterizadas por patologia renal localizada ou intrínseca<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>Para a GESF, os casos primários foram definidos como aqueles que apresentaram SN completa e nenhuma causa secundária identificável. Quando disponível, a microscopia eletrônica confirmou esses casos ao demonstrar o apagamento difuso dos processos podais nos podócitos. A GESF secundária foi caracterizada pelo mesmo padrão histológico, mas foi associada a mecanismos fisiopatológicos subjacentes, como infecções virais, exposição a medicamentos, lesão induzida por hiperfiltração glomerular ou processos adaptativos. Esses casos normalmente não apresentaram proteinúria grave e/ou SN completa, e a microscopia eletrônica, quando disponível, não revelou apagamento difuso de podócitos<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>As variáveis de desfecho analisadas incluíram TFGe inicial e final, proteinúria inicial e final e desfechos clínicos (acompanhamento ambulatorial ativo, perda de seguimento, alta para um ambulatório de DRC, alta da nefrologia, início de TRS e óbito).</p>
<p>As variáveis de acompanhamento incluíram a duração do seguimento, dados clínicos das consultas inicial e final, índice de massa corporal (IMC), pressão arterial sistólica (PAS) e diastólica (PAD) e resultados laboratoriais no início e no final do acompanhamento. As avaliações laboratoriais compreenderam o cálculo da TFGe utilizando a fórmula <em>Chronic Kidney Disease Epidemiology Collaboration</em> (CKD-EPI)<sup>
<a href="#B20" class="usa-link" aria-describedby="B20">20</a>
</sup> e quantificação da proteinúria por meio da coleta de urina de 24 horas ou da relação proteína/creatinina de uma amostra isolada.</p>
<p>Para os pacientes que não foram submetidos à biópsia renal, o diagnóstico de DG foi estabelecido com base em achados clínicos e laboratoriais compatíveis persistentes, tais como hematúria dismórfica e/ou proteinúria, e na ausência de diabetes mellitus, nefrolitíase ou infecção do trato urinário<sup>
<a href="#B7" class="usa-link" aria-describedby="B7">7</a>,<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<p>Este estudo foi realizado em conformidade com a Declaração de Helsinque e foi aprovado pelo Comitê de Ética e Pesquisa do Hospital Universitário da UFJF (CAAE: 47019521.9.0000.5133).</p>
<section id="sec21"><h3 class="pmc_sec_title">Análise Estatística</h3>
<p>Os resultados da análise estatística descritiva foram relatados como médias, desvios-padrão, medianas ou frequências, a depender do tipo de variável (numérica ou categórica) e de sua distribuição (avaliada pelo teste de Kolmogorov-Smirnov). Foram realizadas análises comparativas entre os diagnósticos histopatológicos mais frequentes e os casos sem biópsia renal. Os testes estatísticos incluíram o teste qui-quadrado, o teste t de Student, ANOVA ou o teste de Mann-Whitney, conforme a característica da variável. Testes t pareados foram realizados para comparar a TFGe inicial e final, enquanto testes não paramétricos foram utilizados para a comparação da proteinúria inicial e final em amostras relacionadas. A análise de sobrevida renal foi realizada por meio de curvas de sobrevida de Kaplan-Meier, com comparações avaliadas pelo teste de log-rank. A análise de regressão de Cox foi empregada para avaliar a sobrevida renal como variável de desfecho, com ajuste para fatores de confusão com plausibilidade biológica e/ou estatística. A evolução temporal dos diagnósticos histopatológicos foi analisada, com as frequências expressas como porcentagens ao longo de intervalos de tempo específicos. Todos os testes estatísticos foram realizados com um intervalo de confiança (IC) de 95%. As análises estatísticas foram conduzidas com uso do programa SPSS, versão 17.0 (Chicago, Illinois<sup>®</sup>).</p></section></section><section id="sec22"><h2 class="pmc_sec_title">Resultados</h2>
<section id="sec23"><h3 class="pmc_sec_title">População do Estudo</h3>
<p>Foram selecionados 472 pacientes do ambulatório de Nefrologia especializado em DG da UFJF (janeiro de 1998 a janeiro de 2023). Quarenta e um pacientes foram excluídos por terem menos de 18 anos de idade e 14 foram excluídos pelo fato de as biópsias renais indicarem glomerulonefrite crônica ou não-DG, o que resultou em uma amostra final de 417 pacientes (<a href="#F6" class="usa-link">Figura 1</a>).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Figura 1. Fluxograma do estudo.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf06.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/4d7a66c2b7ff/2175-8239-jbn-47-4-e20240213-gf06.jpg" loading="lazy" height="467" width="800" alt="Figura 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec24"><h3 class="pmc_sec_title">Características da População</h3>
<p>Entre os 417 pacientes, a média de idade foi de 41,7 ± 14,4 anos, 57,3% eram do sexo feminino e 69,8% autodeclarados brancos. A maioria (66,7%) relatou uma renda familiar de até dois salários mínimos, 58,3% possuíam um nível de escolaridade que variou do ensino médio incompleto ao ensino superior e 72,1% estavam empregados. Um total de 323 pacientes (77,5%) foram submetidos à biópsia renal e em 13% houve necessidade de repetir a biópsia para fins terapêuticos ou prognósticos.</p>
<p>O diagnóstico histopatológico mais frequente foi de NL, seguido por GESF, nefropatia por IgA (NIgA) e nefropatia membranosa (NM) (<a href="#F7" class="usa-link">Figura 2</a>). As DGP foram responsáveis por 51,1% dos casos e a NM primária o subtipo mais frequente. Entre as DGS, a NL e a GESF secundária foram as condições mais comuns (<a href="#F8" class="usa-link">Figura 3</a>).</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Figura 2. Diagnóstico histopatológico das doenças glomerulares.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf07.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/7ce995f898e3/2175-8239-jbn-47-4-e20240213-gf07.jpg" loading="lazy" height="457" width="760" alt="Figura 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abreviações – NL (Nefrite Lúpica), NIgA (Nefropatia por IgA), NM (Nefropatia Membranosa), GESF (Glomeruloesclerose Segmentar e Focal), DLM (Doença de Lesão Mínima), Biópsia normal na SAU (Biópsia renal normal na síndrome de anormalidades urinárias), GNMP (Glomerulonefrite Membranoproliferativa), ANCAV (Vasculite associada a ANCA), Outras doenças glomerulares (glomerulonefrite fibrilar; glomerulonefrite mesangial não IgA; glomerulonefrite crescêntica não classificada nas DG anteriores; microangiopatia trombótica), GN relacionada à infecção (glomerulonefrite relacionada à infecção), diagnóstico indefinido (diagnóstico histológico indefinido), GMSR (gamopatia monoclonal de significado renal).</p></figcaption></figure><figure class="fig xbox font-sm" id="F8"><h4 class="obj_head">Figura 3. Diagnóstico histopatológico das doenças glomerulares primárias e secundárias.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf08.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/fbd7f1d91b3b/2175-8239-jbn-47-4-e20240213-gf08.jpg" loading="lazy" height="317" width="760" alt="Figura 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abreviações – DGP (doenças glomerulares primárias), DGS (doenças glomerulares secundárias), NL (Nefrite lúpica), NIgA (Nefropatia por IgA), NM (Nefropatia Membranosa), GESF (Glomeruloesclerose Segmentar e Focal), DLM (Doença de Lesão Mínima), Biópsia normal na SAU (biópsia renal normal na síndrome de anormalidades urinárias), GNMP (Glomerulonefrite membranoproliferativa), ANCAV (Vasculite associada a ANCA), Outras (Outras DG), p (primária), s (secundária).</p></figcaption></figure><p>As comorbidades mais comuns foram HAS, dislipidemia e doenças psiquiátricas. Além disso, 29,7% dos pacientes eram fumantes ou ex-fumantes e 18,7% apresentaram DCV (<a href="#T4" class="usa-link">Tabela 1</a>). Na avaliação inicial, 78,0% tinham um IMC ≥ 25 (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">Tabela 1. Dados clínicos totais, por tipo histológico de doença glomerular e em casos não biopsiados.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1">Variável</th>
<th align="center" valign="top" rowspan="1" colspan="1">Total</th>
<th align="center" valign="top" rowspan="1" colspan="1">NL</th>
<th align="center" valign="top" rowspan="1" colspan="1">NIgA</th>
<th align="center" valign="top" rowspan="1" colspan="1">NM</th>
<th align="center" valign="top" rowspan="1" colspan="1">GESF</th>
<th align="center" valign="top" rowspan="1" colspan="1">DLM</th>
<th align="center" valign="top" rowspan="1" colspan="1">ANCAV</th>
<th align="center" valign="top" rowspan="1" colspan="1">GNMP</th>
<th align="center" valign="top" rowspan="1" colspan="1">Outras<sup>‡</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">Não biopsiados</th>
<th align="center" valign="top" rowspan="1" colspan="1">p</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Idade<a href="#T4FN2" class="usa-link"><sup>*</sup></a> (Anos, Média, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41,7 (14,4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34,8 (10,6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37,5 (12,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48,9 (14,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38,3 (13,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48,7 (14,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52,3 (17,4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47,0 (14,4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43,9 (14,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Pessoas Brancas (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">82,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">78,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">79,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">55,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">75,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">69,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,012</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Mulheres (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">57,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">82,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">47,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">40,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">57,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">67,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hipertensão (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">81,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">92,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">90,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">88,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">63,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">63,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">65,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">64,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diabetes (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">28,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">19,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">27,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,098</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Dislipidemia (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">48,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">62,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">55,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">53,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">35,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,062</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Doenças cardiovasculares (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">32,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">40,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,021</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tabagismo atual ou anterior (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">29,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">46,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">32,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">30</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">39,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">24,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Doença psiquiátrica (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">56,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,004</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Doença óssea (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">19,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">6,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">40,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,320</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">PAS inicial<a href="#T4FN2" class="usa-link"><sup>*</sup></a> (mmHg, Média, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">135,3 (23,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">139,6 (26,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">137,3 (21,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">135,2 (27,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">139,1 (21,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">125,1 (12,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">123,1 (11,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">165,6 (28,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">134,4 (22,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">130,1 (20,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">PAD inicial<a href="#T4FN2" class="usa-link"><sup>*</sup></a> (mmHg, Méda, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">85,1 (14,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87,7 (16,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87,4 (13,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83,8 (13,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87,9 (13,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">80,4 (10,1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">77,8 (10,4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97,4 (14,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83,7 (13,4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">82,3 (14,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,004</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">IMC inicial<a href="#T4FN2" class="usa-link"><sup>*</sup></a> (% ≥25, kg/m<sup>2</sup>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">71,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">82,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">76,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">81,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80</td>
<td align="center" valign="top" rowspan="1" colspan="1">76,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">85,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,600</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Antiproteinúrico (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">89,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">93,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">98,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">96,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">90,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">81,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">71,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">iSGLT2 (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diuréticos (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">73,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">77,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">46,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">92,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">84,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">93,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">59,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">52,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Estatinas (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">53,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">88,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">78,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">80,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">90,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">80,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">57,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">46,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Imunossupressão (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">72,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">55,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">93,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">28,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Corticosteroides (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">59,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">55,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">93,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">23,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Pulsoterapia IV (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">80,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">23,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">81,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">40,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Apresentação nefrológica (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Síndrome nefrótica</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">22,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">92,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">53,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">96,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">8,5</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Síndrome nefrítica</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">6,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Síndrome <br>nefrítica-nefrótica</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">24,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hematúria isolada</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,6</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinúria subnefrótica isolada</td>
<td align="center" valign="top" rowspan="1" colspan="1">14,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">12,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">25,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">23,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">24,5</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hematúria com proteinúria subnefrótica</td>
<td align="center" valign="top" rowspan="1" colspan="1">24,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">58,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinúria nefrótica isolada</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sem dados</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">IRA inicial (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">8,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">70,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">GNRP (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diálise inicial (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Histórico familiar presente (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">26,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">34,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">35,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T4FN1"><p>Legenda: NL (Nefrite Lúpica); NIgA (Nefropatia por IgA); NM (Nefropatia Membranosa); GESF (Glomeruloesclerose Segmentar e Focal); DLM (Doença de Lesão Mínima); GNMP (Glomerulonefrite Membranoproliferativa); ANCAV (Vasculite associada a ANCA); Outras (Outras doenças glomerulares: amiloidose renal, gamopatia monoclonal de significado renal, glomerulonefrite associada à infecção, biópsia normal com hematúria e/ou proteinúria subnefrótica, glomerulonefrite fibrilar, glomerulonefrite mesangial não IgA, glomerulonefrite crescêntica não classificada nas doenças glomerulares anteriores, microangiopatia trombótica, sem diagnóstico histológico definido); Não biopsiados (sem biópsia renal); DP (desvio padrão); % (porcentagem); &lt; (menor); ≥ (maior ou igual); Doenças cardiovasculares (insuficiência cardíaca, ou doença arterial coronariana, ou doença cerebrovascular, ou doença arterial periférica, ou cardiopatia reumática, excluindo hipertensão arterial sistêmica); PAS (pressão arterial sistólica); PAD (pressão arterial diastólica); IMC (índice de massa corporal); Antiproteinúricos (inibidores da enzima conversora de angiotensina, ou bloqueadores do receptor de angiotensina II, ou bloqueadores de aldosterona, ou inibidores do cotransportador de sódio-glicose tipo 2); iSGLT2 (inibidores do cotransportador de sódio-glicose tipo 2); Diuréticos (diurético de alça, diurético tiazídico ou bloqueador de aldosterona); Pulsoterapia IV (pulsoterapia intravenosa); IRA (injúria renal aguda); GNRP (glomerulonefrite rapidamente progressiva);</p></div>
<div class="fn" id="T4FN2"><p>*(no início do acompanhamento).</p></div>
</div></section><p>Com relação ao uso de medicamentos, 89,2% dos pacientes receberam prescrição de antipro­teinúricos, 73,4% utilizaram diuréticos e 61,1% receberam terapia imunossupressora, predomi­nantemente corticosteroides (59%). A pulsoterapia com corticosteroides e/ou ciclofosfamida foi administrada a 30,7% (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<p>A principal apresentação clínica nefrológica foi a SN (33,8%), seguida por hematúria com proteinúria subnefrótica (24,2%) e proteinúria subnefrótica isolada (14,9%). A IRA foi observada em 15,5% dos pacientes, a glomerulonefrite rapidamente progressiva (GNRP) em 8,7% e 4,3% necessitaram de diálise (<a href="#T4" class="usa-link">Tabela 1</a>). O histórico familiar de nefropatia foi relatado em 23,3% (<a href="#T4" class="usa-link">Tabela 1</a>), com maior prevalência entre aqueles com familiares que necessitaram de diálise ou transplante renal (37,4%).</p>
<p>Entre os pacientes submetidos à biópsia renal, 61,8% apresentaram fibrose intersticial e atrofia tubular (FIAT), com média de 20,0% (± 15,8%) de acometimento. A esclerose glomerular foi detectada em 69,3%, as lesões vasculares em 44,4% e as crescentes em 23,8% (predominantemente crescentes celulares – 40,5%) (<a href="#T5" class="usa-link">Tabela 2</a>).</p>
<section class="tw xbox font-sm" id="T5"><h4 class="obj_head">Tabela 2. Dados histopatológicos, laboratoriais e de desfechos clínicos por tipo histológico de doença glomerular e em casos não biopsiados.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1">Variável</th>
<th align="center" valign="top" rowspan="1" colspan="1">Total</th>
<th align="center" valign="top" rowspan="1" colspan="1">NL</th>
<th align="center" valign="top" rowspan="1" colspan="1">NIgA</th>
<th align="center" valign="top" rowspan="1" colspan="1">NM</th>
<th align="center" valign="top" rowspan="1" colspan="1">GESF</th>
<th align="center" valign="top" rowspan="1" colspan="1">DLM</th>
<th align="center" valign="top" rowspan="1" colspan="1">ANCAV</th>
<th align="center" valign="top" rowspan="1" colspan="1">GNMP</th>
<th align="center" valign="top" rowspan="1" colspan="1">Outras<sup>‡</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">Não biopsiados</th>
<th align="center" valign="top" rowspan="1" colspan="1">p</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TFGe (Média, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Inicial</td>
<td align="center" valign="top" rowspan="1" colspan="1">72,9 (33,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79,7 (35,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,0 (29,1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78,1 (30,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67,8 (32,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91,8 (28,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,5 (39,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">42,6 (26,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65,3 (38,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">76,3 (29,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Final</td>
<td align="center" valign="top" rowspan="1" colspan="1">62,5 (33,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">73,6 (34,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48,3 (28,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60,0 (32,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,8 (28,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">85,4 (24,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47,0 (32,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32,3 (15,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">51,7 (31,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70,8 (30,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TFGe inicial <em>vs</em>. final</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>p &lt; 0,001</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinúria (Média, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Inicial</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,7 (4,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,9 (2,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,9 (3,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,9 (4,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,0 (4,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,6 (4,6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,1 (1,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,3 (3,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,6 (2,6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,3 (1,7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Final</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,3 (2,1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,9 (1,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,1 (1,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,3 (2,9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,2 (2,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,7 (1,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,3 (1,3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,2 (5,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,0 (1,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,9 (2,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinúria inicial <em>vs</em>. final</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>p &lt; 0,001</strong>
</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Número de biópsias (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">87,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">75,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">94,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">94,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">92,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">83,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">81,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">90,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">89,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">≥2</td>
<td align="center" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">24,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">18,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Crescentes (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">100,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">% de FIAT (média, DP)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0 (15,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,0 (12,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0 (19,1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0 (13,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20,0 (15,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,0 (5,0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,0 (16,8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,5 (12,2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37,5 (18,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,25</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Esclerose glomerular total ou parcial (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">88,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">51,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">100</td>
<td align="center" valign="top" rowspan="1" colspan="1">46,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">85,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">71,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>&lt; 0,001</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Lesão vascular (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">28,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">47,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">63,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">62,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">37,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">44,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">–</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,010</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Acompanhamento em meses (mediana, IIQ)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,0 (12-99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52,0 (19-66)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64,0 <br>(13-124)</td>
<td align="center" valign="top" rowspan="1" colspan="1">68,0 <br>(24,3-134,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0 <br>(18,8-99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">77,5 <br>(24,8-124)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22,0 <br>(4,5-57,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16,5 <br>(12,3-29,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19,0 <br>(7,5-77,5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40,0 <br>(10-80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,019</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Desfecho clínico (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,002</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Acompanhamento ambulatorial ativo</td>
<td align="center" valign="top" rowspan="1" colspan="1">61,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">77,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">62,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">62,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">59,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">63,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">72,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">50,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">44,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">53,2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Perda de acompanhamento</td>
<td align="center" valign="top" rowspan="1" colspan="1">22,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">17,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">22,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,4</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,9</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Encaminhamento para DRC conservador</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">15,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,6</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diálise</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">4,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,1</td>
<td align="center" valign="top" rowspan="1" colspan="1">30,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Óbito</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,9</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,1</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alta do acompanhamento nefrológico</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,7</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0</td>
<td align="center" valign="top" rowspan="1" colspan="1">3,2</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T5FN1"><p>Legenda: NL (Nefrite Lúpica); NIgA (Nefropatia por IgA); NM (Nefropatia Membranosa); GESF (Glomeruloesclerose Segmentar e Focal); DLM (Doença de Lesão Mínima); GNMP (Glomerulonefrite Membranoproliferativa); ANCAV (Vasculite associada a ANCA); Outras (Outras doenças glomerulares: amiloidose renal, gamopatia monoclonal de significado renal, glomerulonefrite associada à infecção, biópsia normal com hematúria e/ou proteinúria subnefrótica, glomerulonefrite fibrilar, glomerulonefrite mesangial não IgA, glomerulonefrite crescêntica não classificada nas doenças glomerulares anteriores, microangiopatia trombótica, sem diagnóstico histológico definido); Não biopsiados (sem biópsia renal); TFGe (taxa de filtração glomerular estimada); DP (desvio padrão); % (porcentagem); IIQ (intervalo interquartil); &lt; (menor); = (maior ou igual); FIAT (fibrose intersticial e atrofia tubular); DRC (doença renal crônica).</p></div></div></section></section><section id="sec25"><h3 class="pmc_sec_title">Comparação de Diagnósticos Histológicos e Casos não Biopsiados</h3>
<p>Os pacientes com NL apresentaram a menor média de idade, ao passo que os pacientes com glomerulone­frite membranoproliferativa (GNMP) apresentaram a maior. A NL foi mais frequente no sexo feminino, enquanto a vasculite associada a ANCA (ANCAV) e a NM predominaram no sexo masculino. Todos os casos de ANCAV foram observados em pacientes brancos (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<p>A GNMP esteve associada a 100% de prevalência de HAS, enquanto a doença de lesão mínima (DLM) apresentou a menor prevalência de hipertensos (63,3%). Os transtornos psiquiátricos foram mais comuns em pacientes com DLM, e os pacientes com GNMP registraram a maior prevalência de tabagismo. As DCVs foram mais frequentes em pacientes com GNMP e GESF (<a href="#T4" class="usa-link">Tabela 1</a>). A GNMP esteve associada a níveis iniciais significativamente mais elevados de PAS (p &lt; 0,001) e PAD (p = 0,004) (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<p>O uso de medicamentos variou entre os grupos: os antiproteinúricos foram utilizados por todos os pacientes com DLM e GESF e por 71,3% dos casos não biopsiados (p &lt; 0,001). Os diuréticos foram prescritos com maior frequência para pacientes com GNMP (100%), DLM (93,3%), NM (92%) e GESF (84,6%) (p &lt; 0,001). As estatinas foram prescritas com maior frequência em ANCAV (90,9%) e NM (88%) (p &lt; 0,001), ao passo que os inibidores de SGLT2 foram mais comumente utilizados em pacientes com NIgA (31,4%) (p &lt; 0,001) (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<p>A terapia imunossupressora foi administrada em todos os casos de NL e ANCAV e foi também prevalente na DLM (93,3%) e na NM (72,9%) (p &lt; 0,001). A SN predominou em pacientes com DLM (96,7%), NM (92%) e GESF (53,8%). A GNRP foi mais frequente em ANCAV (60,0%) e NL (20,3%), por outro lado nenhum caso foi observado em DLM ou NM (p &lt; 0,001). A ANCAV apresentou a maior necessidade de diálise (30,0%) (p &lt; 0,001) (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<p>A análise histopatológica revelou mais crescentes nos casos de ANCAV (100%) e NL (45,5%) (p &lt; 0,001), enquanto a FIAT foi mais comum em GNMP (88,9%), NIgA (80%) e GESF (79,1%) (p &lt; 0,001). A esclerose glomerular (total ou segmentar, excluindo a GESF) foi prevalente nos casos de NIgA (88,1%) e ANCAV (85,7%), porém menos frequente nos casos de DLM (46,7%) (p &lt; 0,001) (<a href="#T5" class="usa-link">Tabela 2</a>).</p></section><section id="sec26"><h3 class="pmc_sec_title">Desfechos</h3>
<p>Durante o acompanhamento, a TFGe média diminuiu de 72,9 ± 33,3 para 62,5 ± 33,0 (p &lt; 0,001), ao passo que a proteinúria diminuiu de 3,7 ± 4,0 para 1,3 ± 2,1 (p &lt; 0,001) (<a href="#T5" class="usa-link">Tabela 2</a>). A DLM apresentou a melhor sobrevida renal, enquanto a GNMP apresentou os piores desfechos (<a href="#F9" class="usa-link">Figura 4</a>). A maioria dos pacientes (61,4%) permaneceu em acompanhamento, com baixas taxas de TRS crônica (4,6%) ou mortalidade (1,2%) (<a href="#T5" class="usa-link">Tabela 2</a>).</p>
<figure class="fig xbox font-sm" id="F9"><h4 class="obj_head">Figura 4. Curva de sobrevida renal (Kaplan-Meier) na comparação dos principais diagnósticos das doenças glomerulares (log rank 0,001).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf09.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/fdf5f8eee9ab/2175-8239-jbn-47-4-e20240213-gf09.jpg" loading="lazy" height="470" width="760" alt="Figura 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/F9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abreviações – NL (Nefrite Lúpica), NIgA (Nefropatia por IgA), NM (Nefropatia Membranosa), GESF (Glomeruloesclerose Segmentar e Focal), DLM (Doença de Lesão Mínima), GNMP (Glomerulonefrite Membranoproliferativa), ANCAV (Vasculite associada a ANCA), Outras (Outras DG: amiloidose renal; gamopatia monoclonal de significado renal; glomerulonefrite associada à infecção; biópsia normal com hematúria e/ou proteinúria subnefrótica; glomerulonefrite fibrilar; glomerulonefrite mesangial não IgA; glomerulonefrite crescêntica não classificada em DG anteriores; microangiopatia trombótica; sem diagnóstico histológico definido), Sem biópsia renal (Sem biópsia).</p></figcaption></figure><p>A análise de regressão de Cox identificou fatores de proteção para a progressão da DRC, tais como a TFGe basal mais elevada (HR = 0,956, IC95%: 0,920–0,994; p = 0,023). Os fatores de risco para a progressão da DRC incluíram a presença de FIAT (HR = 1,079, IC95%: 1,020–1,142; p = 0,008) e IMC mais alto (HR = 1,257, IC95%: 1,016–1,556; p = 0,035) (<a href="#T6" class="usa-link">Tabela 3</a>).</p>
<section class="tw xbox font-sm" id="T6"><h4 class="obj_head">Tabela 3. Análise de regressão de cox.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5">
<thead>
<tr><th align="center" colspan="4" valign="top" rowspan="1">Análise de regressão de Cox: desfechos de sobrevida renal ajustados para fatores de confusão</th></tr>
<tr style="border-top:solid black 0.1em;border-bottom:solid black 0.1em; border-color: #000000">
<th align="center" valign="top" rowspan="1" colspan="1"></th>
<th align="center" valign="top" rowspan="1" colspan="1">HR</th>
<th align="center" valign="top" rowspan="1" colspan="1">IC 95%</th>
<th align="center" valign="top" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Idade ao diagnóstico de DG</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,041</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,955–1,134</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,366</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sexo feminino</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,163</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,022–1,211</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,076</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">TFGe inicial</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,956</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,920–0,994</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,023</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Proteinúria inicial</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,932</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,687–1,263</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,648</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">DM (diagnóstico presente)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,985</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,153–6,348</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,988</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">IMC inicial</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,257</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,016–1,556</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,035</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">FIAT</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,079</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,020–1,142</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<strong>0,008</strong>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Inibidores da ECA ou bloqueadores do receptor de angiotensina (uso)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83,3</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,420–16502,754</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,101</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Imunossupressão (uso)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,626</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,080–4,881</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,655</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T6FN1"><p>Legenda: DG: doença glomerular; TFGe: taxa de filtração glomerular estimada; DM: diabetes mellitus; IMC: índice de massa corporal; FIAT: fibrose intersticial e atrofia tubular; ECA: enzima conversora de angiotensina; HR: <em>Hazard ratio</em>; IC: Intervalo de confiança.</p></div></div></section><p>Com o tempo, a prevalência de casos de NL aumentou, enquanto as podocitopatias (DLM e GESF) apresentaram redução e a NIgA permaneceu estável (<a href="#F10" class="usa-link">Figura 5</a>).</p>
<figure class="fig xbox font-sm" id="F10"><h4 class="obj_head">Figura 5. Evolução temporal da prevalência dos principais diagnósticos histopatológicos das doenças glomerulares de Janeiro de 1998 a Janeiro de 2023.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12356627_2175-8239-jbn-47-4-e20240213-gf10.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c159/12356627/6deaf53e9aba/2175-8239-jbn-47-4-e20240213-gf10.jpg" loading="lazy" height="528" width="760" alt="Figura 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/F10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p class="font-xs text-right text-italic" aria-label="Attribution">Abreviações – NL (Nefrite Lúpica), NIgA (Nefropatia por IgA), NM (Nefropatia Membranosa), GESF (Glomeruloesclerose Segmentar e Focal), DLM (Doença de Lesão Mínima), GNMP (Glomerulonefrite Membranoproliferativa), ANCAV (Vasculite associada a ANCA).</p></figcaption></figure></section></section><section id="sec27"><h2 class="pmc_sec_title">Discussão</h2>
<p>Nosso estudo confirmou uma mudança no perfil epidemiológico das DG na região ao longo dos últimos 25 anos. Além disso, proporcionou novas percepções ao incorporar dados sobre desfechos renais, juntamente com taxas de prevalência e descrições de diagnósticos histopatológicos.</p>
<p>Um estudo multinacional que analisou a frequência de DG na Europa, América do Norte, América Latina e Ásia relatou uma mediana de idade de 47,3 anos (39,7–56,9), com 53% dos pacientes do sexo masculino e 57% identificando-se como brancos<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>. Os pacientes da América Latina eram mais jovens e predominantemente do sexo feminino, em consonância com nossos achados. Esse perfil demográfico, caracterizado por uma predominância de pacientes jovens do sexo feminino, provavelmente está relacionado à alta prevalência de NL na América Latina e no Brasil, com sugestão de possível componente genético<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>
</sup>.</p>
<p>Sobre esse aspecto, uma proporção significativa de pacientes (23,3%) relatou histórico familiar de nefropatia, o que reforça a influência genética nas DG<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>
</sup>. Um estudo realizado em 163 pacientes com DRC de etiologia desconhecida (2016–2020) identificou um diagnóstico genético definitivo em 31% dos 100 pacientes com DG<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. O sequenciamento do exoma de 111 casos de SN idiopática não revelou variantes patogênicas no grupo sensível a corticosteroides, enquanto 30% dos casos resistentes a corticosteroides abrigaram variantes patogênicas em genes associados a podocitopatias<sup>
<a href="#B24" class="usa-link" aria-describedby="B24">24</a>
</sup>.</p>
<p>Essa população apresentou um alto risco cardiovascular, com comorbidades e eventos clínicos significativos, em consonância com estudos anteriores que ressaltam a conexão entre fatores de risco cardiovascular tradicionais e fatores específicos da DG, nos quais se inclui seu tratamento<sup>
<a href="#B25" class="usa-link" aria-describedby="B25">25</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>. Um estudo de coorte com 1.912 pacientes com DGP (NIgA, GESF, DLM ou NM) constatou que a taxa de eventos cardiovasculares nessa população foi 2,5 vezes maior do que na população geral, e os pacientes com GESF apresentaram o maior risco<sup>
<a href="#B25" class="usa-link" aria-describedby="B25">25</a>
</sup>. Uma coorte dinamarquesa de base populacional com 1.644 pacientes com lúpus eritematoso sistêmico (LES) identificou um risco significativamente maior de infarto agudo do miocárdio (IAM) (aumento de oito vezes) e mortalidade cardiovascular (aumento de quatro vezes) entre pacientes com LES com NL em comparação com aqueles sem NL<sup>
<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>.</p>
<p>Além disso, os transtornos psiquiátricos foram mais frequentes em subgrupos de doenças que demandaram maior uso de corticosteroides - a principal terapia imunossupressora em nosso estudo – o que reforça uma associação bem estabelecida<sup>
<a href="#B27" class="usa-link" aria-describedby="B27">27</a>
</sup>. Em estudo de caso-controle que comparou 50 pacientes com LES e NL, 50 pacientes com LES sem NL e 50 controles saudáveis, foi constatada maior prevalência de ansiedade e depressão entre os pacientes com NL, com risco aumentado naqueles de idade avançada e com maior atividade histológica<sup>
<a href="#B28" class="usa-link" aria-describedby="B28">28</a>
</sup>. Outro estudo que investigou a associação entre transtornos psiquiátricos e DGP entre 950 participantes relatou uma prevalência de 12% de diagnósticos psiquiátricos. Esse diagnóstico foi significativamente associado à progressão da DRC (HR = 2,45, IC 95%: 1,53–3,92)<sup>
<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
<p>O Brasil é um país de dimensões continentais e, como tal, são esperadas variações regionais nos padrões das DG. Segundo dados do Registro Pernambucano de Glomerulopatias de 2017, a região Nordeste relatou que a GESF (43,0%) foi a DGP mais comum, enquanto a NL (67,0%) foi a DGS predominante<sup>
<a href="#B12" class="usa-link" aria-describedby="B12">12</a>
</sup>. Um estudo realizado em 2015 no Ceará encontrou proteinúria na faixa nefrótica em 67,3% dos pacientes, e os diagnósticos histopatológicos mais frequentes foram GESF (19,6%), DLM (17,9%), NM (16,7%) e NL (11,9%)<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>
</sup>. Da mesma forma, um levantamento realizado em 2016 no sul do Brasil encontrou uma maior prevalência de doenças glomerulares secundárias (61,2%), e a NL (30,2%) o diagnóstico mais comum. Entre as DGP, a GESF permaneceu como a mais frequente (10,3%)<sup>
<a href="#B14" class="usa-link" aria-describedby="B14">14</a>
</sup>. Um estudo de 2010 do Distrito Federal relatou a GESF (26,9%) como a DGP mais prevalente, enquanto a NL (50,0%) foi a principal DGS<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>. No norte do Brasil (estado do Amazonas), a GESF também foi identificada como a DG mais comum<sup>
<a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>. Uma análise de cinco anos de casos de DG em São Paulo, publicada no Registro Paulista de Glomerulopatias de 2006, foi realizada com dados de um estudo multicêntrico envolvendo 11 centros que analisaram 1.844 biópsias renais. As DGP mais frequentes foram a GESF (29,7%), a NM (20,7%) e a NIgA (17,8%), ao passo que a NL foi a DGS mais comum (66,2%)<sup>
<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>. O primeiro relatório do Registro Brasileiro de Biópsia Renal foi publicado recentemente. O estudo avaliou 954 biópsias e representou todas as regiões brasileiras. O principal diagnóstico de DG foi NL (22,6%), seguido por NIgA (13%) e GESF (12,2%)<sup>
<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>.</p>
<p>Em nosso estudo, a NL manteve-se como a DGS mais prevalente em nossa região, em consonância com os achados de um estudo internacional de 2018 e de outros estudos brasileiros<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>–<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. No entanto, na análise das DGP, a GESF foi o terceiro diagnóstico mais comum, juntamente com a DLM, atrás da NM e da NIgA. Isso contrasta com estudos anteriores que identificaram a GESF como a DGP mais frequente<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>–<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. Esse achado reflete os avanços na compreensão da fisiopatologia das DG, reconhecendo a GESF não como uma simples doença, mas como um padrão histopatológico de lesão glomerular associado a múltiplos mecanismos patológicos que têm como alvo principal o podócito<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
<p>Com relação a outros achados histopatológicos, nossa análise revelou um perfil sugestivo de cronicidade avançada, o que destaca a necessidade de indicações mais precoces de biópsia renal, mesmo em casos de hematúria glomerular persistente e/ou proteinúria com níveis mais baixos. Um estudo japonês com 552.951 participantes encontrou hematúria em 26,5%, proteinúria ocasional em 10,1% e proteinúria persistente em 1,5%. Além disso, um declínio na TFGe foi associado tanto à hematúria isolada quanto ao seu efeito sinérgico com a proteinúria<sup>
<a href="#B32" class="usa-link" aria-describedby="B32">32</a>
</sup>.</p>
<p>Ao longo do acompanhamento, a TFGe diminuiu, enquanto os níveis de proteinúria apresentaram melhora. Esses achados provavelmente refletem a progressão da doença, com uma redução da TFGe ao longo do tempo, e os efeitos do tratamento - tanto imunossupressores quanto não imunossupressores – na evolução da proteinúria. Indicadores adicionais de desfechos favoráveis incluem que a maioria dos pacientes permanece em acompanhamento ativo, com baixas taxas de progressão para TRS e/ou mortalidade.</p>
<p>A sobrevida renal foi mais elevada na DLM e mais baixa na GNMP. Em nosso estudo, os pacientes com DLM eram mais jovens, apresentaram escores mais baixos de FIAT e de lesões vasculares e exibiram valores mais altos de TFGe inicial e final. Eles também apresentaram maiores reduções na proteinúria, sugerindo uma resposta terapêutica positiva e remissão da doença. Um estudo de análise de risco sobre a progressão da DRC, necessidade de TRS, eventos cardiovasculares e mortalidade em 907 adultos com SN primária (DLM, GESF ou NM), em comparação com um grupo controle saudável, identificou riscos menores em pacientes com DLM, exceto para tromboembolismo venoso<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. Os pacientes com GNMP em nosso estudo apresentaram a maior média de idade, indicadores histológicos sugestivos de cronicidade, níveis mais baixos de TFGe inicial e final e melhora mínima na proteinúria, o que indica uma pior resposta terapêutica. Um estudo brasileiro que analisou 53 casos de GNMP relatou remissão parcial ou completa em apenas 39% dos pacientes<sup>
<a href="#B34" class="usa-link" aria-describedby="B34">34</a>
</sup>.</p>
<p>A sobrevida renal em casos não biopsiados foi semelhante à observada na NIgA. Um estudo recente encontrou piores desfechos em casos de NIgA e GESF, com taxas mais elevadas de progressão para TRS<sup>
<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>. Esses achados reforçam ainda mais a necessidade de reconsiderar as indicações de biópsia renal para anormalidades urinárias persistentes que, tradicionalmente, podem não justificar a avaliação histopatológica, bem como a importância de expandir as análises genéticas<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>,<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>.</p>
<p>Os principais fatores associados à progressão da DRC foram a TFGe inicial mais baixa, a presença de FIAT e o IMC mais alto. A associação entre menor TFGe basal e piores desfechos pode refletir a seleção de casos com maior gravidade clínica e/ou histopatológica no início da doença. Um estudo coreano que analisou 1.943 biópsias renais de pacientes com DGP constatou uma pior progressão da doença naqueles com TFGe abaixo de 60 mL/min/1,73m<sup>2 <a href="#B36" class="usa-link" aria-describedby="B36">36</a>
</sup>. Além disso, a gravidade da FIAT é um achado classicamente associado à cronicidade e a desfechos desfavoráveis<sup>
<a href="#B37" class="usa-link" aria-describedby="B37">37</a>
</sup>. A obesidade é um fator de risco bem estabelecido para DRC e tem sido especificamente relacionada às glomerulopatias<sup>
<a href="#B38" class="usa-link" aria-describedby="B38">38</a>
</sup>. Uma revisão sistemática e meta-análise de casos de NIgA constatou que os pacientes com sobrepeso e obesidade apresentavam TFGe mais baixa em comparação com aqueles com IMC normal<sup>
<a href="#B39" class="usa-link" aria-describedby="B39">39</a>
</sup>. Um estudo japonês que analisou 489 pacientes com NL identificou o IMC e a TFGe basal como fatores de risco independentes para a progressão da DRC<sup>
<a href="#B40" class="usa-link" aria-describedby="B40">40</a>
</sup>.</p>
<p>As principais limitações deste estudo incluíram o período de análise prolongado, que levou à perda de acompanhamento de alguns pacientes, e restrições na coleta de dados devido ao seu delineamento retrospectivo, uma vez que se baseou exclusivamente em registros médicos. Semelhante à maioria dos estudos sobre esse tema, nossa investigação concentrou-se nos padrões histopatológicos das lesões glomerulares, e não em sua fisiopatologia subjacente<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>–<a href="#B18" class="usa-link" aria-describedby="B18">18</a>
</sup>. A próxima etapa lógica é aprofundar a avaliação de cada subgrupo de lesões, inclusive daquelas que não foram submetidas à análise histológica. Esse aprofundamento deve combinar métodos descritivos, analíticos e inferenciais, integrados a novas abordagens clínicas, laboratoriais e genéticas.</p>
<p>Em conclusão, a NL permaneceu como a DGS mais prevalente em nossa região, enquanto a GESF e a DLM ocuparam o terceiro lugar entre as DGP, após a NM e a NIgA. A sobrevida renal foi mais elevada na DLM e mais baixa na GNMP. A compreensão do perfil epidemiológico das DG em nosso meio é fundamental para o desenvolvimento de políticas de saúde voltadas ao cuidado integral desse grupo específico de pacientes com doença renal.</p></section><section id="ack2" class="ack"><h2 class="pmc_sec_title">Agradecimentos</h2>
<p>Unidade de Atenção Integral à Doença Renal Crônica do HU-UFJF/EBSERH, Faculdade de Medicina da UFJF – Juiz de Fora, MG, Brasil.</p></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN4"><p><strong>Financiamento:</strong> CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior).</p></div></div></section><section id="sec28"><h2 class="pmc_sec_title">Disponibilidade de Dados</h2>
<p>Os dados serão compartilhados mediante solicitação razoável ao autor correspondente.</p></section></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data will be shared upon reasonable request to the corresponding author.</p>
<p>Os dados serão compartilhados mediante solicitação razoável ao autor correspondente.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Jornal Brasileiro de Nefrologia are provided here courtesy of <strong>Sociedade Brasileira de Nefrologia</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1590/2175-8239-JBN-2024-0213en"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/2175-8239-jbn-47-4-e20240213.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (437.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12356627/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12356627/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12356627%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12356627/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12356627/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12356627/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40815784/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12356627/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40815784/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12356627/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12356627/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="oj9o57pZb5LyLwKNdt2vCVxxciFccDHghLd9O4ZR4JowoqWzDB5y3i488PQL0DFL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
